<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Psychol Med</journal-id><journal-id journal-id-type="iso-abbrev">Psychol Med</journal-id><journal-id journal-id-type="publisher-id">PSM</journal-id><journal-title-group><journal-title>Psychological Medicine</journal-title></journal-title-group><issn pub-type="ppub">0033-2917</issn><issn pub-type="epub">1469-8978</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40230302</article-id><article-id pub-id-type="pmc">PMC12094621</article-id>
<article-id pub-id-type="doi">10.1017/S0033291725000844</article-id><article-id pub-id-type="pii">S0033291725000844</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Sleep and schizophrenia polygenic scores in non-affective and affective psychotic disorders</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2911-1794</contrib-id><name><surname>Cederl&#x000f6;f</surname><given-names>Erik</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Holm</surname><given-names>Minna</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>K&#x000e4;mpe</surname><given-names>Anders</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ahola-Olli</surname><given-names>Ari</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kantoj&#x000e4;rvi</surname><given-names>Katri</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>L&#x000e4;hteenvuo</surname><given-names>Markku</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ahti</surname><given-names>Johan</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hietala</surname><given-names>Jarmo</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>H&#x000e4;kkinen</surname><given-names>Katja</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Isomets&#x000e4;</surname><given-names>Erkki</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tuulio-Henriksson</surname><given-names>Annamari</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kampman</surname><given-names>Olli</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref><xref rid="aff9" ref-type="aff">
<sup>9</sup>
</xref><xref rid="aff10" ref-type="aff">
<sup>10</sup>
</xref><xref rid="aff11" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lahdensuo</surname><given-names>Kaisla</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>L&#x000f6;nnqvist</surname><given-names>Jouko</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tiihonen</surname><given-names>Jari</given-names></name><xref rid="aff12" ref-type="aff">
<sup>12</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Turunen</surname><given-names>Hannu</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wegelius</surname><given-names>Asko</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Veijola</surname><given-names>Juha</given-names></name><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="aff13" ref-type="aff">
<sup>13</sup>
</xref><xref rid="aff14" ref-type="aff">
<sup>14</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kiesepp&#x000e4;</surname><given-names>Tuula</given-names></name><xref rid="aff15" ref-type="aff">
<sup>15</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Palotie</surname><given-names>Aarno</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Paunio</surname><given-names>Tiina</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="cor1" ref-type="corresp"/></contrib></contrib-group><aff id="aff1"><label>1</label><institution>Finnish Institute for Health and Welfare</institution>, <city>Helsinki</city>, <country>Finland</country></aff><aff id="aff2"><label>2</label>Department of Psychiatry, <institution>University of Helsinki and Helsinki University Hospital</institution>, <city>Helsinki</city>, <country>Finland</country></aff><aff id="aff3"><label>3</label>SleepWell Research Program, Faculty of Medicine, <institution>University of Helsinki and Helsinki University Hospital</institution>, <city>Helsinki</city>, <country>Finland</country></aff><aff id="aff4"><label>4</label>Institute for Molecular Medicine FIMM, <institution>University of Helsinki</institution>, <city>Helsinki</city>, <country>Finland</country></aff><aff id="aff5"><label>5</label>Niuvanniemi Hospital, <institution>University of Eastern</institution>, <city>Kuopio</city>, <country>Finland</country></aff><aff id="aff6"><label>6</label>Faculty of Medicine, <institution>University of Turku</institution>, <city>Turku</city>, <country>Finland</country></aff><aff id="aff7"><label>7</label>Department of Psychology and Logopedics, Faculty of Medicine, <institution>University of Helsinki</institution>, <city>Helsinki</city>, <country>Finland</country></aff><aff id="aff8"><label>8</label>Department of Psychiatry, <institution>The Pirkanmaa Wellbeing Services County</institution>, <city>Tampere</city>, <country>Finland</country></aff><aff id="aff9"><label>9</label>Faculty of Medicine and Health Technology, <institution>University of Tampere</institution>, <city>Tampere</city>, <country>Finland</country></aff><aff id="aff10"><label>10</label>Department of Clinical Sciences, Psychiatry, <institution>Ume&#x000e5; University</institution>, <city>Ume&#x000e5;</city>, <country>Sweden</country></aff><aff id="aff11"><label>11</label>Department of Psychiatry, <institution>The Wellbeing Services County of Ostrobothnia</institution>, <city>Vaasa</city>, <country>Finland</country></aff><aff id="aff12"><label>12</label>Department of Clinical Neuroscience, <institution>Karolinska Institutet</institution>, <city>Stockholm</city>, <country>Sweden</country></aff><aff id="aff13"><label>13</label>Department of Psychiatry, Research Unit of Clinical Neuroscience, <institution>University of Oulu</institution>, <city>Oulu</city>, <country>Finland</country></aff><aff id="aff14"><label>14</label>Medical Research Center, <institution>University of Oulu and Oulu University Hospital</institution>, <city>Oulu</city>, <country>Finland</country></aff><aff id="aff15"><label>15</label><institution>Finnish Ministry of Social Affairs and Health</institution>, <city>Helsinki</city>, <country>Finland</country></aff><author-notes><corresp id="cor1"><bold>Corresponding authors:</bold> Erik Cederl&#x000f6;f and Tiina Paunio; Emails: <email>erik.cederlof@helsinki.fi</email>; <email>tiina.paunio@helsinki.fi</email></corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2025"><year>2025</year></pub-date><pub-date pub-type="epub"><day>15</day><month>4</month><year>2025</year></pub-date><volume>55</volume><elocation-id>e117</elocation-id><history><date date-type="received"><day>05</day><month>9</month><year>2024</year></date><date date-type="rev-recd"><day>27</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>20</day><month>3</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0</uri>), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0033291725000844a.pdf"/><abstract><sec id="sec1"><title>Background</title><p>Sleep problems are common in psychotic disorders and are associated with worse quality of life and disease prognosis. Genome-wide association studies (GWAS) have revealed genetic influences for schizophrenia and sleep, but polygenic scores (PGSs) for sleep traits have not been evaluated systematically in patients with psychotic disorders.</p></sec><sec id="sec2"><title>Methods</title><p>This study investigated the associations between PGSs for sleep traits (insomnia, PGS<sub>INS</sub>; sleep duration, PGS<sub>SD</sub>; short sleep duration, PGS<sub>SS</sub>; long sleep duration; PGS<sub>LS</sub>), diurnal preference (eveningness, PGS<sub>ME</sub>), and schizophrenia (PGS<sub>SZ</sub>) with clinical features of psychotic disorders in the Finnish SUPER study comprising 8,232 patients with psychotic disorders. The measures included self-reported sleep and well-being, cognitive assessments, clozapine use, and functional outcomes. Using FinnGen data of 356,077 individuals, we analyzed the distributions of PGSs in psychotic and bipolar disorders and the general population.</p></sec><sec id="sec3"><title>Results</title><p>PGS<sub>INS</sub> associated with more sleep problems and worse well-being (e.g. worse health-related quality of life [&#x003b2;&#x000a0;=&#x000a0;&#x02212;0.07, CI&#x000a0;=&#x000a0;&#x02212;0.09, &#x02212;0.05, <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;.001]). High PGS<sub>SZ</sub> is associated with better sleep quality, worse clinical outcomes, and performance in cognitive tests (e.g. more errors in paired-associated learning [&#x003b2;&#x000a0;=&#x000a0;0.07, CI&#x000a0;=&#x000a0;0.04, 0.09, <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;.001]). PGS<sub>INS</sub> was higher in affective psychotic and bipolar disorders, while PGS<sub>SD</sub> and PGS<sub>ME</sub> were higher in schizophrenia as compared with individuals with no psychiatric disorders.</p></sec><sec id="sec4"><title>Conclusion</title><p>Genetic risks for sleep and diurnal preference vary between non-affective psychosis, affective psychosis, and the general population. The findings in this study emphasize the heterogeneity in genetic etiology of the objective features of disease severity and the more subjective measures related to well-being and self-reported measures of sleep.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>cognition</kwd><kwd>polygenic scores</kwd><kwd>psychotic disorders</kwd><kwd>schizophrenia</kwd><kwd>sleep</kwd></kwd-group><funding-group><award-group id="aw001"><funding-source>
<institution-wrap><institution>Academy of Finland</institution><institution-id institution-id-type="doi">http://doi.org/10.13039/501100002341</institution-id></institution-wrap>
</funding-source><award-id>357643</award-id><principal-award-recipient>Tiina Paunio</principal-award-recipient></award-group><award-group id="aw002"><funding-source>
<institution-wrap><institution>Svenska S&#x000e4;llskapet f&#x000f6;r Medicinsk Forskning</institution><institution-id institution-id-type="doi">http://doi.org/10.13039/501100003748</institution-id></institution-wrap>
</funding-source><award-id>PD20-0190</award-id><principal-award-recipient>Anders K&#x000e4;mpe</principal-award-recipient></award-group><award-group id="aw003"><funding-source>
<institution-wrap><institution>Finska L&#x000e4;kares&#x000e4;llskapet</institution><institution-id institution-id-type="doi">http://doi.org/10.13039/100010135</institution-id></institution-wrap>
</funding-source><award-id>8-1353-9</award-id><principal-award-recipient>Tiina Paunio</principal-award-recipient></award-group><award-group id="aw004"><funding-source>
<institution-wrap><institution>Helsingin ja Uudenmaan Sairaanhoitopiiri</institution><institution-id institution-id-type="doi">http://doi.org/10.13039/100008376</institution-id></institution-wrap>
</funding-source><award-id>TYH2021328</award-id><principal-award-recipient>Tiina Paunio</principal-award-recipient></award-group></funding-group><counts><fig-count count="2"/><table-count count="3"/><ref-count count="68"/><page-count count="10"/></counts></article-meta></front><body><sec sec-type="intro" id="sec5"><title>Introduction</title><p>Schizophrenia is among the most severe and debilitating psychiatric disorders, significantly impacting the quality of life and general functioning (Dong et al., <xref rid="r16" ref-type="bibr">2019</xref>; Green, Kern, &#x00026; Heaton, <xref rid="r24" ref-type="bibr">2004</xref>; Holm, Taipale, Tanskanen, Tiihonen, &#x00026; Mitterdorfer-Rutz, <xref rid="r27" ref-type="bibr">2021</xref>; Saarni et al., <xref rid="r59" ref-type="bibr">2010</xref>). It is characterized by a combination of neuropsychological mechanisms that result in disturbed mental processes (Palmer, Dawes, &#x00026; Heaton, <xref rid="r48" ref-type="bibr">2009</xref>). Cognitive impairment is one of the most robust endophenotypes in schizophrenia and is also common in patients with other psychotic disorders (including schizoaffective disorder, bipolar disorder, and psychotic depression) (Barch &#x00026; Ceaser, <xref rid="r6" ref-type="bibr">2012</xref>; Green &#x00026; Harvey, <xref rid="r23" ref-type="bibr">2014</xref>; Lepage, Bodnar, &#x00026; Bowie, <xref rid="r37" ref-type="bibr">2014</xref>; Li et al., <xref rid="r38" ref-type="bibr">2020</xref>).</p><p>Patients with psychotic disorders often experience sleep problems, including insomnia and hypersomnia symptoms (Freeman, Sheaves, Waite, Harvey, &#x00026; Harrison, <xref rid="r20" ref-type="bibr">2020</xref>; Krystal, <xref rid="r33" ref-type="bibr">2012</xref>; Reeve, Sheaves, &#x00026; Freeman, <xref rid="r54" ref-type="bibr">2019</xref>, <xref rid="r55" ref-type="bibr">2021</xref>). In our previous study, patients with affective psychotic disorders exhibited more insomnia symptoms than patients with schizophrenia, who more often experienced excessively long sleep (37% of patients with schizophrenia, compared with 24% of patients with psychotic depression, as derived from previously published data). These sleep problems are associated strongly with worse subjective health (Cederl&#x000f6;f et al., <xref rid="r9" ref-type="bibr">2022</xref>). Both sleep problems and cognitive impairments have been linked to negative outcomes, including a worse quality of life (DeRosse, Nitzburg, Blair, &#x00026; Malhotra, <xref rid="r14" ref-type="bibr">2018</xref>; Ritsner, Kurs, Ponizovsky, &#x00026; Hadjez, <xref rid="r57" ref-type="bibr">2004</xref>).</p><p>Genome-wide association studies (GWAS) have identified multiple risk variants for schizophrenia (Trubetskoy et al., <xref rid="r64" ref-type="bibr">2022</xref>) and other psychiatric disorders and traits, leading to the development of polygenic scores (PGSs). PGS for schizophrenia (PGS<sub>SZ</sub>) has a considerable explanatory effect for schizophrenia and weaker but significant associations also with schizoaffective disorder and bipolar disorder type 1 (Allardyce et al., <xref rid="r3" ref-type="bibr">2018</xref>; Sullivan et al., <xref rid="r60" ref-type="bibr">2018</xref>). A high PGS<sub>SZ</sub> has in patients with schizophrenia been previously associated with poorer quality of life (Pazoki et al., 2020), more involuntary hospitalizations (Meier et al., <xref rid="r42" ref-type="bibr">2016</xref>), and clozapine use (Lin et al., <xref rid="r39" ref-type="bibr">2023</xref>). Poor cognitive functioning has been associated with PGS<sub>SZ</sub> in the general population and first-episode psychosis cohorts, but not in schizophrenia(Jonas et al., <xref rid="r30" ref-type="bibr">2019</xref>; Mallet, Strat, Dubertret, &#x00026; Gorwood, <xref rid="r41" ref-type="bibr">2020</xref>; Richards et al., <xref rid="r56" ref-type="bibr">2020</xref>). Studies on associations between PGS<sub>SZ</sub> and sleep in adulthood are scarce. One study with a general population sample, including a subsample of patients with schizophrenia, found associations between PGS<sub>SZ</sub> and early morning awakenings, reduced sleep efficiency, and increased napping (Wainberg et al., <xref rid="r65" ref-type="bibr">2021</xref>).</p><p>Well-established PGSs for sleep traits include those for insomnia (PGS<sub>INS</sub>) (Lane et al., <xref rid="r36" ref-type="bibr">2017</xref>) and sleep duration (PGS<sub>SD</sub>) (Dashti, Redline, &#x00026; Saxena, <xref rid="r12" ref-type="bibr">2019</xref>), and for diurnal preference (PGS<sub>ME</sub>) (Jones et al., <xref rid="r31" ref-type="bibr">2019</xref>; Wray et al., <xref rid="r67" ref-type="bibr">2014</xref>; Zhang, Priv&#x000e9;, Vilhj&#x000e1;lmsson, &#x00026; Speed, <xref rid="r68" ref-type="bibr">2021</xref>). PGSs for short (PGS<sub>SS</sub>) and long sleep duration (PGS<sub>LS</sub>) have also recently been created (Austin-Zimmerman et al., <xref rid="r5" ref-type="bibr">2023</xref>). These PGSs have been derived from self-report data in the general population, in whom they have been shown to have a relatively modest impact on sleep-related measures. Sleep PGSs have in genetic correlation studies been found to correlate with various psychiatric disorders and traits, including both affective disorders and PGS<sub>SZ.</sub> (; Dashti, Redline, &#x00026; Saxena, <xref rid="r12" ref-type="bibr">2019</xref>; Jansen et al., <xref rid="r29" ref-type="bibr">2019</xref>; Jones et al., <xref rid="r31" ref-type="bibr">2019</xref>; O&#x02019;Connell et al., <xref rid="r47" ref-type="bibr">2021</xref>). Few studies on sleep or diurnal preference PGSs in psychiatric disorders have been done. In one study, high PGS<sub>SD</sub> was not associated with schizophrenia or bipolar disorder (Dashti et al., <xref rid="r11" ref-type="bibr">2019</xref>).</p><p>In this study, we aimed to compare genetic influences on objective measures of disease severity and subjective measures related to life quality and sleep in patients with psychotic disorders in a systematically collected nationwide sample. Specifically, we aimed to clarify the relationship between PGSs of sleep, diurnal traits, and schizophrenia, with (1) self-reported measures on sleep, subjective health, and cognitive functioning and (2) objective measures including involuntary hospitalizations and cognitive performance) in a large sample of patients with psychotic disorders. We hypothesized that genetic predisposition for sleep and diurnal traits are primarily related to subjective measures, while that for schizophrenia is mainly related to objective measures. Finally, to potentially shed light on the mechanisms of sleep problems in psychotic disorders, we (3) explored differences in these PGSs in non-affective and affective psychotic disorders, as compared with individuals with no psychiatric disorders from the general population.</p></sec><sec sec-type="materials" id="sec6"><title>Materials and methods</title><sec sec-type="other" id="sec7"><title>Study sample</title><p>This study is part of the SUPER research project, which examines psychotic disorders. The SUPER project is part of the international Stanley Global Neuropsychiatric Genomics Initiative. In Finland, the Institute for Molecular Medicine Finland (FIMM), the Finnish Institute of Health and Welfare (THL), and the University of Helsinki oversaw the research project. The project was carried out in cooperation with all hospital districts in Finland.</p></sec><sec sec-type="other" id="sec8"><title>SUPER cohort</title><p>Adult Finnish patients with schizophrenia spectrum disorders (ICD-10 codes: F20&#x02013;F29), bipolar disorder, or psychotic depression (ICD-10 codes: F30.2, F31, F32.3, and F33.3) with a history of at least one psychotic episode were eligible to participate. The diagnoses were retrieved from the Finnish Care Register for Health Care (HILMO). Finnish registry data have been shown to be of high-quality, including for mental health diagnoses (Sund, <xref rid="r61" ref-type="bibr">2012</xref>). In the present study, patients with (1) schizophrenia, (2) schizoaffective disorder, (3) bipolar disorder, or (4) psychotic depression were included. These diagnoses were categorized into diagnostic groups of (1) schizophrenia and (2) affective psychotic disorders, including schizoaffective disorder, bipolar disorder, and psychotic depression. The questionnaire, interview, cognitive tests, and genetic sampling were all conducted during the same session with a study nurse. The complete study protocol and further information about the study population were published previously (Ahola-Olli et al., <xref rid="r35" ref-type="bibr">2023</xref>).</p><p>The total sample size was 10,411 patients. Patients with an unknown or other diagnosis than the four diagnostic groups, those who did not complete the questionnaire, were older than 80&#x000a0;years (or no age registered), or had no or subpar genotypic information, were excluded. After exclusion 8,232 patients remained. For the study sample flow chart, see <uri xlink:href="http://doi.org/10.1017/S0033291725000844">Supplementary&#x000a0;Figure&#x000a0;1</uri>.</p></sec><sec sec-type="other" id="sec9"><title>PGS calculation</title><p>All PGSs were based on PRS-CS (Ge, Chen, Ni, Feng, &#x00026; Smoller, <xref rid="r21" ref-type="bibr">2019</xref>), using the largest publicly available summary statistics for each trait. These included the PGS for insomnia (Lane et al., <xref rid="r36" ref-type="bibr">2017</xref>), sleep duration (Dashti, Redline, &#x00026; Saxena, <xref rid="r31" ref-type="bibr">2019</xref>), schizophrenia (Trubetskoy et al., <xref rid="r64" ref-type="bibr">2022</xref>), as well as the PGSs for long and short sleep duration (Austin-Zimmerman et al., <xref rid="r5" ref-type="bibr">2023</xref>). The PGS for eveningness was derived from a PGS originally developed for morningness (Jones et al., <xref rid="r31" ref-type="bibr">2019</xref>). The entire genome was used, meaning all reliably imputed SNPs that intersected with each trait&#x02019;s GWAS summary statistics were included. The Illumina Global Screening Array was used to genotype all participants. Samples where the inferred sex was mismatched with the recorded sex were excluded, as were samples with poor genotype quality. Imputation was performed using a Finnish-specific reference panel SISu version 3 (P&#x000e4;rn et al., <xref rid="r49" ref-type="bibr">n.d.</xref>) and only reliably imputed variants (INFO score&#x000a0;&#x0003e;&#x000a0;0.8) were kept. Ancestral outliers (<italic toggle="yes">N</italic>&#x000a0;=&#x000a0;71, as defined by being &#x0003e;5 standard deviations from European samples in principal components 1 and 2), were not excluded. The LASER suit was used to infer ancestry (Taliun et al., <xref rid="r63" ref-type="bibr">2017</xref>).</p></sec><sec sec-type="other" id="sec10"><title>Measures</title><sec sec-type="other" id="sec11"><title>Questionnaire-based measures for sleep, well-being, and subjective cognitive functioning</title><p>The sleep questions assessed total sleep duration, from which <italic toggle="yes">long</italic> and <italic toggle="yes">short SD</italic> were calculated, difficulties initiating sleep (<italic toggle="yes">DIS</italic>), early morning awakenings (<italic toggle="yes">EMAs</italic>), fatigue (<italic toggle="yes">FAT</italic>), and poor sleep quality (<italic toggle="yes">poor SQ</italic>) (for questions and response categories, see <xref rid="tab1" ref-type="table">Table 1</xref>) (Cederl&#x000f6;f et al., <xref rid="r9" ref-type="bibr">2022</xref>). The questions were based on Finnish general population studies (Aromaa &#x00026; Koskinen, <xref rid="r4" ref-type="bibr">2004</xref>; Heistaro, <xref rid="r25" ref-type="bibr">2008</xref>; Partinen &#x00026; Gislason, <xref rid="r50" ref-type="bibr">1995</xref>), and for subjective well-being, the measures included <italic toggle="yes">subjective health</italic> (Heistaro, <xref rid="r25" ref-type="bibr">2008</xref>), health-related quality of life (assessed with EQ-5D-3L, hereafter referred to as <italic toggle="yes">EQ5D</italic>) (Devlin &#x00026; Krabbe, <xref rid="r15" ref-type="bibr">2013</xref>; Saarni et al., <xref rid="r58" ref-type="bibr">2006</xref>), <italic toggle="yes">psychological distress</italic> (assessed with the Mental Health Inventory&#x02013;5 [<italic toggle="yes">MHI-5</italic>], according to RAND scoring instructions) (Aalto, Aro, Aro, M&#x000e4;h&#x000f6;nen, &#x00026; Aro, <xref rid="r1" ref-type="bibr">1995</xref>; Berwick et al., <xref rid="r7" ref-type="bibr">1991</xref>). Questions of <italic toggle="yes">subjective cognitive functioning</italic> included questions on concentration, learning, and memory (Heistaro, <xref rid="r25" ref-type="bibr">2008</xref>; Koponen, Borodulin, Lundqvist, S&#x000e4;&#x000e4;ksj&#x000e4;rvi, &#x00026; Koskinen, <xref rid="r32" ref-type="bibr">2018</xref>). Poor subjective cognitive functioning was defined as giving the response poor or very poor to any of the three questions, a dummy variable previously used in Finnish population-based studies (Koponen et al., <xref rid="r32" ref-type="bibr">2018</xref>).<table-wrap position="float" id="tab1"><label>Table 1.</label><caption><p>Questions used in the study</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Questions</th><th align="left" valign="bottom" rowspan="1" colspan="1">Answers</th><th align="left" valign="bottom" rowspan="1" colspan="1">Categorized as</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Total sleep duration, TSD</italic>: How long do you usually sleep at night? How long do you usually sleep during the daytime?<break/>
</td><td align="left" valign="top" rowspan="1" colspan="1">The patient wrote the number of hours and minutes for both questions freely. The night and day sleep were summed into TSD and compared with the Health 2000 study question &#x02018;How many hours do you sleep per day?&#x02019;</td><td align="left" valign="top" rowspan="1" colspan="1">Responses that had missing or unreasonable answers to the sleep duration question (TSD&#x000a0;&#x0003c;&#x000a0;2 hours or&#x000a0;&#x02265;&#x000a0;18 hours) were excluded. Long SD was defined as sleeping 10 hours or more and short SD as sleeping 6 hours or less.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Difficulty initiating sleep, DIS</italic>: Do you have difficulties falling asleep without sleep medication?</td><td align="left" valign="top" rowspan="1" colspan="1">Not at all, sometimes, often, and nearly always.</td><td align="left" valign="top" rowspan="1" colspan="1">DIS was defined as &#x02018;often&#x02019; and &#x02018;nearly always&#x02019;.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Early morning awakenings, EMAs</italic>: Do you wake up during sleep at night or very early in the morning?</td><td align="left" valign="top" rowspan="1" colspan="1">Not at all, sometimes, often, and nearly always.</td><td align="left" valign="top" rowspan="1" colspan="1">EMAs were defined as &#x02018;often&#x02019; and &#x02018;nearly always&#x02019;.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Fatigue, FAT</italic>: Do you consider yourself to be fatigued more often than other people of the same age during the daytime?</td><td align="left" valign="top" rowspan="1" colspan="1">Yes, nearly always; yes, often (at least weekly); no; I cannot say.</td><td align="left" valign="top" rowspan="1" colspan="1">FAT was defined as &#x02018;Yes, nearly always&#x02019; and &#x02018;yes, often&#x02019;.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Sleep quality, SQ</italic>: How well have you slept during the last month?<break/>
</td><td align="left" valign="top" rowspan="1" colspan="1">Well, rather well, neither well nor poorly, rather poorly, poorly.</td><td align="left" valign="top" rowspan="1" colspan="1">Poor SQ was defined as having slept &#x02018;rather poorly&#x02019; or &#x02018;poorly&#x02019;.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Subjective health</italic>: Assess your own current state of health by entering the number that best corresponds to your current state of health.</td><td align="left" valign="top" rowspan="1" colspan="1">Numeric scale from 0 to 10.</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Health-related quality of life, EQ5D</italic>
<break/>Please tick the one box that best describes your health today.<break/>
</td><td align="left" valign="top" rowspan="1" colspan="1">3-level answer categories for mobility, self-care, usual activities, pain/discomfort, and anxiety/depression</td><td align="left" valign="top" rowspan="1" colspan="1">Converted to a linear 0&#x02013;1 variable based on country-specific conversion factors</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Mental Health Inventory&#x02013;5, MHI&#x02013;5</italic>
<break/>Please tick the one box that best describes your health today.<break/>
</td><td align="left" valign="top" rowspan="1" colspan="1">5 questions on mental health and psychological distress</td><td align="left" valign="top" rowspan="1" colspan="1">The scores from the five questions were converted, added together, and used as a linear variable.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">Subjective cognitive functioning</italic>
<break/>
<italic toggle="yes">Focus:</italic> How well are you usually able to focus?<break/>
<italic toggle="yes">Memory:</italic> How do you rate how your memory functions?<break/>
<italic toggle="yes">Learning:</italic> How do you rate your ability to learn new things?</td><td align="left" valign="top" rowspan="1" colspan="1">Very well, well, satisfactorily, poorly, and very poorly</td><td align="left" valign="top" rowspan="1" colspan="1">Poor subjective focus, memory, or learning was defined as &#x02018;poorly&#x02019; or &#x02018;very poorly&#x02019;. A combined dummy variable named &#x02018;poor subjective cognition&#x02019; was created which was defined as having answered &#x02018;poorly&#x02019; or &#x02018;very poorly in any of the three questions.</td></tr></tbody></table><graphic xlink:href="S0033291725000844_tab2" position="float"/></alternatives></table-wrap></p></sec><sec sec-type="other" id="sec12"><title>Assessment of objective cognitive functioning</title><p>Two tests were used: the <italic toggle="yes">Reaction Time (RTI)</italic> and the <italic toggle="yes">Paired Associative Learning (PAL)</italic> task, both from the Cambridge Neuropsychological Test Automated Battery (CANTAB). Five-choice serial reaction time task (5-CRTT) measured RTI to an unpredictable stimulus and hence general alertness and processing speed, while PAL measured visual and episodic learning and memory (CANTAB).</p><p>Our outcome for the RTI test was the median five-choice reaction time (RTIFMDRT), that is the median latency of response. The variable was calculated for correct responses where the stimulus could appear in any of the five locations. In the PAL test, our outcome was the Total Errors Adjusted (PALTEA), which reflects how quickly the participant learns when the participant has multiple attempts at each problem.</p></sec><sec sec-type="other" id="sec13"><title>Interview</title><p>Marital status (marriage, common-law marriage, registered partnership), living status (unsupported versus supported housing), <italic toggle="yes">participation in the workforce</italic> (full- or part-time work, or student status), and education (register data obtained when interview data was unavailable) were asked in the interview.</p><p>
<italic toggle="yes">Clozapine use</italic> was applied as an indicator of disease severity, as it is typically used in treatment-resistant psychotic disorders (Elkis &#x00026; Buckley, <xref rid="r17" ref-type="bibr">2016</xref>). Information on medications was retrieved from a question in the interview: &#x02018;What medications do you use regularly?&#x02019; The names of the medicines were checked on the label or the prescription form unless the interviewee remembered them.</p></sec></sec><sec sec-type="other" id="sec14"><title>FinnGen cohort</title><p>The FinnGen cohort data was used for analyzing the distribution of PGSs across the diagnostic groups and the general population. FinnGen is a public-private partnership, which combines genome information and digital healthcare data (Kurki et al., <xref rid="r34" ref-type="bibr">2023</xref>). In this study, we used FinnGen Release 8, which comprises 356,077 Finnish individuals. We categorized the sample, using the same ICD-codes as in SUPER, into people with (1) schizophrenia (<italic toggle="yes">N</italic>&#x000a0;=&#x000a0;6,280), (2) schizoaffective, bipolar disorder, or psychotic depression (<italic toggle="yes">N</italic>&#x000a0;=&#x000a0;8,177), and (3) no psychiatric disorder (<italic toggle="yes">N</italic>&#x000a0;=&#x000a0;251,638). Exactly 4,708 patients with schizophrenia and 3,511 patients with affective psychotic disorders were also included in the SUPER study. PGSs in FinnGen were calculated with the PRS-CS method (Ge et al., <xref rid="r21" ref-type="bibr">2019</xref>). A total of 3,511 patients were found both in the FinnGen and the SUPER sample, but only 3,078 patients in SUPER (before applying inclusion criteria) had a diagnosis of schizoaffective disorder, bipolar disorder, or psychotic depression. This is likely due to diagnoses used in drug purchases and reimbursements being available in FinnGen, while only Finnish Care Register for Health Care (HILMO) diagnoses are available in the SUPER study. HILMO recognizes mostly only diagnoses made in the public health care system of Finland. An additional difference between the samples is that SUPER recruited patients with at least one psychotic episode in their medical history, and this does not apply to patients with bipolar disorder in the FinnGen study. Hence, this group from the FinnGen sample is referred to as &#x02018;affective psychotic and bipolar disorders&#x02019;.</p></sec><sec sec-type="other" id="sec15"><title>Statistical analysis</title><p>For analyzing associations between PGSs and outcomes, we conducted regression analyses in SPSS version 29.0, with age, gender, diagnostic group (schizophrenia and affective psychotic disorders), the first four principal components to control for population stratification, and one PGS value as independent variables. Logistic regression was conducted for the dichotomized dependent variables of sleep traits, subjective cognitive functioning, clozapine use, and work status, and linear regression was performed for MHI-5, EQ5D, RT, PAL, and days in involuntary hospitalization. We used a Bonferroni&#x02013;Holm correction (0.05/14 [number of outcomes]&#x000a0;=&#x000a0;0.0036 as the lowest significant threshold) to correct for multiple analyses (Aickin &#x00026; Gensler, <xref rid="r2" ref-type="bibr">1996</xref>). In supplemental analyses, we conducted the same analyses separately in the two diagnostic groups. Nagelkerke&#x02019;s <italic toggle="yes">R</italic><sup>2</sup> was used to assess the proportion of variance explained by PGS<sub>SD</sub> and PGS<sub>INS</sub> (Nagelkerke, <xref rid="r45" ref-type="bibr">1991</xref>).</p><p>To analyze the distribution of the PGSs in the FinnGen cohort, we conducted binomial regression analyses in R version 4.1.3. The first four principal components and gender were included as covariates. The PGS was the independent variable, while the diagnosis was the dependent variable. A Bonferroni&#x02013;Holm correction (0.05/6 [amount of PGSs]&#x000a0;=&#x000a0;0.0083) was used to correct for multiple analyses. The regression analyses were conducted separately for the two diagnostic groups, and people with no psychiatric disorders were the reference group. We replicated the full FinnGen sample analyses, with the two subsamples of (1) patients who were a part of both FinnGen and the SUPER study, and (2) the patients in FinnGen who were not in the SUPER study.</p></sec></sec><sec sec-type="results" id="sec16"><title>Results</title><sec sec-type="other" id="sec17"><title>Demographics</title><p>The largest diagnostic group was patients with schizophrenia (demographics in <xref rid="tab2" ref-type="table">Table 2</xref>). Patients with schizophrenia had on average a longer time since the first diagnosis of psychosis (22.0 vs. 12.9&#x000a0;years), lower level of education, and lower participation in the workforce than patients with affective psychotic disorders.<table-wrap position="float" id="tab2"><label>Table 2.</label><caption><p>Demographics of the SUPER study</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1" valign="bottom"/><th align="center" colspan="1" valign="bottom" rowspan="1">SZ</th><th align="center" colspan="1" valign="bottom" rowspan="1">Affective psychotic disorders (SZ-A, BPD, and Ps-DEP)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Proportion of sample, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">5353 (65.0)</td><td align="center" valign="top" rowspan="1" colspan="1">2879 (35.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender (Men), <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">3069 (57.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1079 (37.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18&#x02013;40&#x000a0;years, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">1674 (31.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1185 (41.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">41&#x02013;60&#x000a0;years, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">2460 (46.0)</td><td align="center" valign="top" rowspan="1" colspan="1">1210 (42.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">61&#x02013;80&#x000a0;years, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">1219 (22.8)</td><td align="center" valign="top" rowspan="1" colspan="1">484 (16.8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, <italic toggle="yes">M</italic> (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">48.3 (13.9)</td><td align="center" valign="top" rowspan="1" colspan="1">45.1 (14.6)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Years since onset, <italic toggle="yes">M</italic> (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">22.0 (12.8)</td><td align="center" valign="top" rowspan="1" colspan="1">12.9 (8.9)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Low level of education, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">2166 (40.5)</td><td align="center" valign="top" rowspan="1" colspan="1">656 (22.8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intermediate level of education, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">2345 (43.8)</td><td align="center" valign="top" rowspan="1" colspan="1">1381 (48.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">High level of education, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">820 (15.3)</td><td align="center" valign="top" rowspan="1" colspan="1">839 (29.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Married/cohabiting, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">695 (13.0)</td><td align="center" valign="top" rowspan="1" colspan="1">952 (33.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Participation in workforce</td><td align="center" valign="top" rowspan="1" colspan="1">395 (7.7)</td><td align="center" valign="top" rowspan="1" colspan="1">507 (18.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Living independently</td><td align="center" valign="top" rowspan="1" colspan="1">3151 (59.5)</td><td align="center" valign="top" rowspan="1" colspan="1">2477 (87.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Clozapine medication</td><td align="center" valign="top" rowspan="1" colspan="1">2014 (38.3)</td><td align="center" valign="top" rowspan="1" colspan="1">233 (8.4)</td></tr></tbody></table><graphic xlink:href="S0033291725000844_tab1" position="float"/></alternatives><table-wrap-foot><p>
<italic toggle="yes">Note:</italic> SZ, schizophrenia; SZ-A, schizoaffective disorder; BD, bipolar disorder; Ps-DEP, psychotic depression.</p></table-wrap-foot></table-wrap></p></sec><sec sec-type="other" id="sec18"><title>Sleep-related measures</title><p>Using polygenic scores for sleep traits, diurnal preference (eveningness), and schizophrenia, we investigated how the polygenic burden was associated with sleep problems within the psychotic disorder spectrum (<xref rid="fig1" ref-type="fig">Figure 1</xref> and <uri xlink:href="http://doi.org/10.1017/S0033291725000844">Supplementary&#x000a0;Table&#x000a0;1</uri>). PGS<sub>INS</sub>, PGS<sub>SD</sub>, and PGS<sub>SS</sub> showed the strongest impact on sleep. After Bonferroni&#x02013;Holm correction, high PGS<sub>INS</sub> was significantly associated with DIS (OR = 1.18, 95 % CI = 1.12&#x02013;1.24, <italic toggle="yes">p</italic> = 7.12 &#x000d7; 10<sup>&#x02212;11</sup>), EMAs (OR = 1.11, CI = 1.06&#x02013;1.17, <italic toggle="yes">p</italic> = 6.60 &#x000d7; 10<sup>&#x02212;6</sup>), poor SQ (OR = 1.22, CI = 1.15&#x02013;1.30, <italic toggle="yes">p</italic> = 8.68 &#x000d7; 10<sup>&#x02212;10</sup>), and FAT (OR = 1.08, CI = 1.03&#x02013;1.13, <italic toggle="yes">p</italic> = .002), and similar findings were observed with PGS<sub>SS</sub> (DIS, OR = 1.18, CI = 1.05&#x02013;1.17, <italic toggle="yes">p</italic> = 7.20 &#x000d7; 10<sup>&#x02212;5</sup>; EMAs, OR = 1.08, CI = 1.03&#x02013;1.13, <italic toggle="yes">p</italic> = .001; short SD, OR = 1.18, CI = 1.09&#x02013;1.27, <italic toggle="yes">p</italic> = 6.15 &#x000d7; 10<sup>&#x02212;5</sup>; poor SQ, OR = 1.18, CI = 1.11&#x02013;1.26, <italic toggle="yes">p</italic> = 4.53 &#x000d7; 10<sup>&#x02212;4</sup>). High PGS<sub>SD</sub> was associated with less EMAs (OR = 0.92, CI = 0.87&#x02013;0.96, <italic toggle="yes">p</italic> = 4.41 &#x000d7; 10<sup>&#x02212;4</sup>), better SQ (OR = 0.87, CI = 0.82&#x02013;0.93, <italic toggle="yes">p</italic> = 3.87 &#x000d7; 10<sup>&#x02212;5</sup>), and with longer SD (short SD, OR = 0.86, CI = 0.79&#x02013;0.93, <italic toggle="yes">p</italic> = 1.83 &#x000d7; 10<sup>&#x02212;4</sup>; long SD, OR = 1.09, CI = 1.03&#x02013;1.14, <italic toggle="yes">p</italic> = .001). PGS<sub>LS</sub> was only associated with more EMAs (OR = 1.07, CI = 1.02&#x02013;1.12, <italic toggle="yes">p</italic> = .003) and PGS<sub>ME</sub> was not significantly associated with any of the sleep outcomes. High PGS<sub>SZ</sub> was associated with less EMAs (OR = 0.90, CI = 0.86&#x02013;0.95, <italic toggle="yes">p</italic> = 2.34 &#x000d7; 10<sup>&#x02212;4</sup>) and better sleep quality (poor SQ, OR = 0.87, CI = 0.81&#x02013;0.94, <italic toggle="yes">p</italic> = 2.88 &#x000d7; 10<sup>&#x02212;4</sup>). In a linear regression analysis of sleep duration, PGS<sub>SD</sub> explained 0.3% of the variation in phenotypic sleep duration, while 0.9% of poor SQ variance, as measured by Nagelkerke <italic toggle="yes">R</italic><sup>2</sup>, was explained by PGS<sub>INS</sub>.<fig position="float" id="fig1"><label>Figure 1.</label><caption><p>Results from logistic and linear regression analyses for the polygenic scores. For congruency, the outcomes of subjective health, MHI-5, and EQ5D were inversed for this figure. Darker gray indicates positive coefficients (representing a worse outcome), while lighter gray indicates negative coefficients. *&#x000a0;=&#x000a0;significant after Bonferroni&#x02013;Holm correction. All results significant before correction (<italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) are colored. <italic toggle="yes">Note</italic>: PGSs in rows: INS, &#x02018;insomnia&#x02019;; SD, &#x02018;sleep duration&#x02019;; ME, &#x02018;morning-eveningness (chronotype)&#x02019;; SZ, &#x02018;schizophrenia&#x02019;; MHI-5, &#x02018;Mental Health Inventory -5&#x02019;; EQ5D, &#x02018;Health-related quality of life&#x02019;.</p></caption><graphic xlink:href="S0033291725000844_fig1" position="float"/></fig></p></sec><sec sec-type="other" id="sec19"><title>Well-being and subjective cognitive functioning</title><p>PGS<sub>INS</sub> was the only PGS with significant associations (<xref rid="fig1" ref-type="fig">Figure 1</xref> and <uri xlink:href="http://doi.org/10.1017/S0033291725000844">Supplementary&#x000a0;Tables&#x000a0;2</uri> and <uri xlink:href="http://doi.org/10.1017/S0033291725000844">3</uri>), and the score was associated with all non-sleep subjective measures, including poorer subjective cognitive functioning (OR&#x000a0;=&#x000a0;1.14, CI&#x000a0;=&#x000a0;1.09&#x02013;1.20, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;1.86&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02013;7</sup>), poorer subjective health, &#x003b2;&#x000a0;=&#x000a0;&#x02212;0.06, CI&#x000a0;=&#x000a0;&#x02212;0.08, &#x02212;0.03, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;5.23&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;7</sup>), worse EQ5D (&#x003b2;&#x000a0;=&#x000a0;&#x02212;0.07, CI&#x000a0;=&#x000a0;&#x02212;0.09, -0.05, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;1.89&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;9</sup>) and MHI-5 (&#x003b2;&#x000a0;=&#x000a0;&#x02212;0.06, CI&#x000a0;=&#x000a0;&#x02212;0.08, &#x02212;0.02, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;4.05&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;8</sup>).</p></sec><sec sec-type="other" id="sec20"><title>Cognitive tests and measures for disease severity</title><p>Mainly PGS<sub>SZ</sub> had significant associations with objective outcomes (<xref rid="fig1" ref-type="fig">Figure 1</xref> and <uri xlink:href="http://doi.org/10.1017/S0033291725000844">Supplementary&#x000a0;Table&#x000a0;4</uri>), including worse results in PAL (&#x003b2;&#x000a0;=&#x000a0;0.07, CI&#x000a0;=&#x000a0;0.04, 0.09, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;1.60&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02013;6</sup>) and RTI (&#x003b2;&#x000a0;=&#x000a0;0.05, CI&#x000a0;=&#x000a0;0.02, 0.07, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;.001), and more frequent clozapine use (OR&#x000a0;=&#x000a0;1.15, CI&#x000a0;=&#x000a0;1.08&#x02013;1.22, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;6.13&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;7</sup>). PGS<sub>INS</sub>, and PGS<sub>SS</sub> were associated with a lower risk of unemployment (OR&#x000a0;=&#x000a0;0.89, CI&#x000a0;=&#x000a0;0.83&#x02013;0.96, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;.003, and OR&#x000a0;=&#x000a0;0.88, CI&#x000a0;=&#x000a0;0.82&#x02013;0.95, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;.002, respectively).</p><p>In analyses with diagnostic splits (<uri xlink:href="http://doi.org/10.1017/S0033291725000844">Supplementary&#x000a0;Table&#x000a0;7</uri>), the association between high PGS<sub>SZ</sub> and worse performance in PAL and RTI remained significant only in patients with affective psychotic disorders.</p></sec><sec sec-type="other" id="sec21"><title>Distribution of PGSs across the diagnostic spectrum and the general population</title><p>We investigated the difference in the distribution of PGSs in diagnostic groups (schizophrenia and affective psychotic and bipolar disorders) compared with people with no psychiatric disorders (<xref rid="fig2" ref-type="fig">Figure 2</xref> for boxplot, <xref rid="tab3" ref-type="table">Table 3</xref>). When analyzing the full FinnGen sample, patients with schizophrenia had a very strong association with PGS<sub>SZ</sub>, and associations with PGS<sub>SD</sub> (OR&#x000a0;=&#x000a0;1.09, CI&#x000a0;=&#x000a0;1.06&#x02013;1.11, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;1&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;10</sup>) and PGS<sub>LS</sub> (OR&#x000a0;=&#x000a0;1.09, CI&#x000a0;=&#x000a0;1.06&#x02013;1.12, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;2&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;11</sup>), and associations with PGS<sub>ME</sub> (OR&#x000a0;=&#x000a0;1.06, CI&#x000a0;=&#x000a0;1.04&#x02013;1.09, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;2&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;6</sup>), and PGS<sub>SS</sub> (OR&#x000a0;=&#x000a0;0.96, CI&#x000a0;=&#x000a0;0.92&#x02013;0.98, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;.002). For patients with affective bipolar and psychotic disorders, there were associations with PGS<sub>SZ</sub>, PGS<sub>INS</sub> (OR&#x000a0;=&#x000a0;1.08, CI&#x000a0;=&#x000a0;1.05&#x02013;1.10, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;3&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;12</sup>), PGS<sub>LS</sub> (OR&#x000a0;=&#x000a0;1.12, CI&#x000a0;=&#x000a0;1.09&#x02013;1.14, <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;2&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;16</sup>), and an association with PGS<sub>SS</sub> (OR&#x000a0;=&#x000a0;1.05, CI&#x000a0;=&#x000a0;1.03&#x02013;1.07, 1&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;5</sup>).<fig position="float" id="fig2"><label>Figure 2.</label><caption><p>Boxplot showing the distribution of polygenic scores across different diagnostic groups.</p></caption><graphic xlink:href="S0033291725000844_fig2" position="float"/></fig>
<table-wrap position="float" id="tab3"><label>Table 3.</label><caption><p>Results from linear regression analyses of PGSs in the diagnostic groups, compared with people with no psychiatric disorder</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Outcome diagnosis</th><th align="center" colspan="3" valign="bottom" rowspan="1">Schizophrenia PGS</th><th align="center" colspan="3" valign="bottom" rowspan="1">Sleep duration PGS</th><th align="center" colspan="3" valign="bottom" rowspan="1">Insomnia PGS</th><th align="center" colspan="3" valign="bottom" rowspan="1">Eveningness PGS</th><th align="center" colspan="3" valign="bottom" rowspan="1">Long sleep duration PGS</th><th align="center" colspan="3" valign="bottom" rowspan="1">Short sleep duration PGS</th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Full Finngen sample</th><th align="center" valign="bottom" rowspan="1" colspan="1">OR</th><th align="center" valign="bottom" rowspan="1" colspan="1">CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">OR</th><th align="center" valign="bottom" rowspan="1" colspan="1">CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">OR</th><th align="center" valign="bottom" rowspan="1" colspan="1">CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">OR</th><th align="center" valign="bottom" rowspan="1" colspan="1">CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">OR</th><th align="center" valign="bottom" rowspan="1" colspan="1">CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">OR</th><th align="center" valign="bottom" rowspan="1" colspan="1">CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Schizophrenia (<italic toggle="yes">N</italic> = 6,280)</td><td align="center" valign="top" rowspan="1" colspan="1">2.39</td><td align="center" valign="top" rowspan="1" colspan="1">2.32&#x02013;2.46</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c; 2 &#x000d7; 10<sup>&#x02212;16</sup></td><td align="center" valign="top" rowspan="1" colspan="1">1.09</td><td align="center" valign="top" rowspan="1" colspan="1">1.06&#x02013;1.11</td><td align="center" valign="top" rowspan="1" colspan="1">1 &#x000d7; 10<sup>&#x02212;10</sup></td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td><td align="center" valign="top" rowspan="1" colspan="1">0.97&#x02013;1.02</td><td align="center" valign="top" rowspan="1" colspan="1">.698</td><td align="center" valign="top" rowspan="1" colspan="1">1.06</td><td align="center" valign="top" rowspan="1" colspan="1">1.04&#x02013;1.09</td><td align="center" valign="top" rowspan="1" colspan="1">2 &#x000d7; 10<sup>&#x02212;6</sup></td><td align="center" valign="top" rowspan="1" colspan="1">1.09</td><td align="center" valign="top" rowspan="1" colspan="1">1.06&#x02013;1.12</td><td align="center" valign="top" rowspan="1" colspan="1">2 &#x000d7; 10<sup>&#x02212;11</sup></td><td align="center" valign="top" rowspan="1" colspan="1">0.96</td><td align="center" valign="top" rowspan="1" colspan="1">0.94&#x02013;0.98</td><td align="center" valign="top" rowspan="1" colspan="1">.002</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Affective psychotic and bipolar disorders (<italic toggle="yes">N</italic> = 9,563)</td><td align="center" valign="top" rowspan="1" colspan="1">1.64</td><td align="center" valign="top" rowspan="1" colspan="1">1.60&#x02013;1.67</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c; 2 &#x000d7; 10<sup>&#x02212;16</sup></td><td align="center" valign="top" rowspan="1" colspan="1">1.02</td><td align="center" valign="top" rowspan="1" colspan="1">1.00&#x02013;1.05</td><td align="center" valign="top" rowspan="1" colspan="1">.026</td><td align="center" valign="top" rowspan="1" colspan="1">1.08</td><td align="center" valign="top" rowspan="1" colspan="1">1.05&#x02013;1.10</td><td align="center" valign="top" rowspan="1" colspan="1">3 &#x000d7; 10<sup>&#x02212;12</sup></td><td align="center" valign="top" rowspan="1" colspan="1">1.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.99&#x02013;1.03</td><td align="center" valign="top" rowspan="1" colspan="1">.319</td><td align="center" valign="top" rowspan="1" colspan="1">1.12</td><td align="center" valign="top" rowspan="1" colspan="1">1.09&#x02013;1.14</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c; 2 &#x000d7; 10<sup>&#x02212;16</sup></td><td align="center" valign="top" rowspan="1" colspan="1">1.05</td><td align="center" valign="top" rowspan="1" colspan="1">1.03&#x02013;1.07</td><td align="center" valign="top" rowspan="1" colspan="1">1 &#x000d7; 10<sup>&#x02212;5</sup></td></tr></tbody></table><graphic xlink:href="S0033291725000844_tab3" position="float"/></alternatives></table-wrap></p><p>A separate analysis of (1) SUPER patients and (2) patients only in FinnGen (<uri xlink:href="http://doi.org/10.1017/S0033291725000844">Supplementary&#x000a0;Table&#x000a0;8</uri>), found similar patterns of associations in both data sets for PGS<sub>SZ</sub>. In SUPER, PGS<sub>SD</sub> was associated with affective psychotic disorders, as did PGS<sub>ME</sub> with marginal statistical evidence. These associations were not found in Finngen, or in the complete data set. PGS<sub>SZ</sub> was higher in the SUPER sample than in the FinnGen sample.</p></sec></sec><sec sec-type="discussion" id="sec22"><title>Discussion</title><p>To the best of our knowledge, this is the first systematic study on polygenic influences for sleep traits in psychotic disorders. We found that sleep PGSs, derived from the general population, are significantly associated with sleep traits also in this population with psychiatric comorbidity and high rates of sleep-impacting medications (Cederl&#x000f6;f et al., <xref rid="r10" ref-type="bibr">2024</xref>). Additionally, we identified varied distributions of sleep PGSs across non-affective and affective psychotic disorders and individuals with no psychiatric disorder. A high genetic risk for insomnia was consistently associated with worse well-being, while that for schizophrenia had an impact on objective measures, including poorer performance in cognitive tests and more clozapine use.</p><p>Different types of sleep problems have been previously linked to psychotic disorders in clinical studies, where they are often considered secondary to the disorder or medication (Krystal, <xref rid="r33" ref-type="bibr">2012</xref>), albeit our findings in non-medicated patients show that they also present more frequently with both insomnia and hypersomnia symptoms than the general population (Cederl&#x000f6;f et al., <xref rid="r9" ref-type="bibr">2022</xref>, <xref rid="r10" ref-type="bibr">2024</xref>). Our present finding on the association of sleep PGSs to sleep traits in psychotic disorders shows how intrinsic genetic vulnerability for insomnia independently links to sleep problems. On the other hand, the lack of association of the sleep PGSs to any of the objective measures was striking. For example, while PGS<sub>INS</sub> was associated significantly with subjective experience of impaired cognitive functioning, it was not correlated with the objective measures of cognition (vigilance or verbal learning). Contrary to this, PGS<sub>SZ</sub> was not linked to subjective but only to worse objective measures on cognitive functions, potentially linked to sleep spindle and slow-wave abnormalities observed in earlier studies of patients with schizophrenia (Ferrarelli, <xref rid="r18" ref-type="bibr">2021</xref>). Furthermore, PGS<sub>SZ</sub> correlated negatively with subjective experiences of sleep problems. Thus, according to these findings, sleep symptoms seem to form a separate domain of symptoms with distinctive etiological influences among patients with psychotic disorders.</p><p>In our attempt to find differences in genetic influences on non-affective and affective psychosis, we found a consistent pattern of deviating risks in both datasets, the SUPER sample and the FinnGen data. As expected, PGS<sub>SZ</sub> is associated robustly with schizophrenia, showing a &#x0003e;&#x000a0;2-fold risk compared with the general population (Allardyce et al., <xref rid="r3" ref-type="bibr">2018</xref>; Sullivan et al., <xref rid="r60" ref-type="bibr">2018</xref>). It was also elevated in affective psychotic and bipolar disorders but with a lower OR. PGS<sub>INS</sub> was significantly higher among patients with affective psychotic disorders, but not among those with schizophrenia, as compared with the general population. This finding supports the previously well-known role of insomnia as a risk factor for affective disorders (Hertenstein, Benz, Schneider, &#x00026; Baglioni, <xref rid="r26" ref-type="bibr">2023</xref>).</p><p>Regarding the three PGSs related to sleep duration, we observed a pattern in which patients with schizophrenia had higher levels of the PGS<sub>SD</sub> and PGS<sub>LS</sub> scores (reflecting genetic propensities for long sleep duration), while patients with affective psychotic and bipolar disorders had elevated levels of both PGS<sub>LS</sub> and PGS<sub>SS</sub> (reflecting genetic propensities for both short and long sleep duration). The finding on schizophrenia supports the role of genetic influences in our earlier observation of longer sleep duration in psychotic disorders compared with the general population (Cederl&#x000f6;f et al., <xref rid="r9" ref-type="bibr">2022</xref>). Comprehensively, our findings provide evidence of distinct patterns of genetic sleep-related risks in non-affective and affective psychosis.</p><p>Previous studies have proposed diurnal preference for eveningness as a risk for compromised mental health, in particular depression (Norbury, <xref rid="r46" ref-type="bibr">2021</xref>), and according to some studies, schizophrenia and bipolar disorder as well (Linke &#x00026; Jankowski, <xref rid="r40" ref-type="bibr">2021</xref>). In this study, PGS<sub>ME</sub> was not associated significantly with any subjective or objective measures among the SUPER patients. In the full FinnGen data, there was, however, a significant and relatively robust correlation to schizophrenia but not to affective psychotic and bipolar disorders. One potential mechanism underlying eveningness-type of diurnal preference is a slower dynamic of sleep pressure build-up and dissipation(Mongrain &#x00026; Dumont, <xref rid="r44" ref-type="bibr">2007</xref>; Taillard, Philip, Coste, Sagaspe, &#x00026; Bioulac, <xref rid="r62" ref-type="bibr">2003</xref>). Our findings for PGS<sub>SD</sub> and PGSME suggest the presence of deviating processes in homeostatic sleep regulation in schizophrenia &#x02013; a conclusion that would be in line with the previous studies indicating slow-wave sleep deficits in schizophrenia (Ferrarelli, <xref rid="r18" ref-type="bibr">2021</xref>).</p><p>
<italic toggle="yes">Strengths and limitations.</italic> Our study comprised a large nationwide sample of patients with psychotic disorders, combining genetic information with rich phenotype data including extensive subjective metrics and cognitive tests. The use of the FinnGen database enabled novel large-sample analyses on sleep PGSs in the different diagnostic groups. There are, however, some limitations that should be considered when interpreting the findings. It is important to note that these findings were derived from a relatively homogenous population, which can be advantageous for some of the exploratory investigations presented in this article; however, this homogeneity may also limit the generalizability of the results (Woodward, Urbanowicz, Naj, &#x00026; Moore, <xref rid="r66" ref-type="bibr">2022</xref>). The impact of sleep PGSs was modest on sleep phenotypes, in line with previous studies in the general population and patients with major depressive disorder (Dashti, Jones, et al., <xref rid="r31" ref-type="bibr">2019</xref>; Melhuish Melhuish Beaupre et al., <xref rid="r43" ref-type="bibr">2021</xref>). Second, self-assessment of cognition and sleep is known to be deficient in patients with psychotic disorders, as factors such as depressed mood can exaggerate symptoms (Demant, Vinberg, Kessing, &#x00026; Miskowiak, <xref rid="r13" ref-type="bibr">2015</xref>; Gonzalez, Tamminga, Tohen, &#x00026; Suppes, <xref rid="r22" ref-type="bibr">2013</xref>; Raffard, Lebrun, Bayard, Macgregor, &#x00026; Capdevielle, <xref rid="r52" ref-type="bibr">2020</xref>), while simultaneously some patients may have limited awareness of their cognitive deficits (Homayoun, Nadeau-Marcotte, Luck, &#x00026; Stip, <xref rid="r28" ref-type="bibr">2011</xref>; Prouteau, Roux, Destaillats, &#x00026; Bergua, <xref rid="r51" ref-type="bibr">2017</xref>). Moreover, the cognitive measures could also be more extensive and include domains such as executive functions or social cognition (CANTAB). Finally, we did not have objective sleep data in the present study. Such data would be valuable not only in considering the modest effect of sleep PGSs on objective sleep in the general population (Dashti, Jones, et al., <xref rid="r31" ref-type="bibr">2019</xref>; Foldager et al., <xref rid="r19" ref-type="bibr">2022</xref>), but also in further elucidating potential pathogenic sleep-related processes in psychotic disorders.</p></sec><sec sec-type="conclusions" id="sec23"><title>Conclusions</title><p>Sleep PGSs derived from the general population influence self-reported sleep also in persons with psychotic disorders. PGS<sub>INS</sub> is associated with worse subjective well-being, but not with cognitive deficits or other objective measures of disease severity, while PGS<sub>SZ</sub> is related to worse objective measures, but not to worse subjective measures. Our findings underscore the importance of sleep for the quality of life of patients, and the etiologic heterogeneity between core objective elements of psychotic disorders and the subjective measures related to sleep and well-being.</p></sec><sec sec-type="supplementary-material" id="sec27"><title>Supporting information</title><supplementary-material id="sm01" position="float" content-type="local-data"><caption><title>Cederl&#x000f6;f et al. supplementary material</title><p>Cederl&#x000f6;f et al. supplementary material</p></caption><media xlink:href="S0033291725000844sup001.docx" id="d67e1754" position="anchor"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>We want to thank all study participants in both SUPER and FinnGen for making this study possible. We also want to thank the entire SUPER-Finland study group, including: Aija Kytt&#x000e4;l&#x000e4; (Finnish Institute for Health and Welfare), Auli Toivola (Finnish Institute for Health and Welfare), Benjamin Neale (Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard), Huei-yi Shen (Institute for Molecular Medicine Finland), Imre V&#x000e4;strik (Institute for Molecular Medicine Finland), Jouko L&#x000f6;nnqvist (Finnish Institute for Health and Welfare), Jussi Niemi-Pyntt&#x000e4;ri (Psychiatric and Substance Abuse Services, City of Helsinki), Katja H&#x000e4;kkinen (Niuvanniemi Hospital, University of Eastern Finland), Kimmo Suokas (Faculty of Social Sciences, Tampere University), Mark Daly (Institute for Molecular Medicine Finland), Noora Ristiluoma (Finnish Institute for Health and Welfare), Olli Pietil&#x000e4;inen (Neuroscience Center, HiLIFE, University of Helsinki), Risto Kajanne (Institute for Molecular Medicine Finland), Steven E. Hyman (Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard), Tarjinder Singh (Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard), Teemu M&#x000e4;nnynsalo (Psychiatric and Substance Abuse Services, City of Helsinki), Tuomas Jukuri (Medical Research Center, University of Oulu and Oulu University Hospital), Willehard Haaki (Faculty of Medicine, University of Turku).</p></ack><sec sec-type="supplementary-material" id="nts1"><title>Supplementary material</title><p>The supplementary material for this article can be found at <uri xlink:href="http://doi.org/10.1017/S0033291725000844">http://doi.org/10.1017/S0033291725000844</uri>.</p></sec><sec sec-type="funding-statement" id="sec24"><title>Funding statement</title><p>This work was supported by the Stanley Center for Psychiatric Research at Broad Institute. Cederl&#x000f6;f and Paunio were supported by grants from Finska L&#x000e4;kares&#x000e4;llskapet (#9-1600-15 and #8-1353-9), HUS (TYH2021328) and Academy of Finland (#357643). Holm was supported by a grant from the Academy of Finland (#310295). K&#x000e4;mpe was supported by Svenska s&#x000e4;llskapet f&#x000f6;r medicinsk forskning, SSMF (# PD20-0190). The funding organizations had no role in the design or execution of the study; in the collection, management, analysis, or interpretation of data; in the preparation, review, or approval of the manuscript; or in the decision to submit the manuscript for publication.</p></sec><sec sec-type="COI-statement" id="sec25"><title>Competing interests</title><p>Regarding conflicts of interest, Markku L&#x000e4;hteenvuo is an owner and board member of Genomi Solutions Ltd. and Nursie Health Ltd. and has received honoraria from Sunovion, Orion Pharma, Janssen-Cilag, Otsuka Pharma, Lundbeck, and Medscape, travel funds from Sunovion, and research grants from the Finnish Medical Foundation, the Emil Aaltonen Foundation, and the Finnish Cultural Foundation. Jari Tiihonen has participated in research projects funded by grants from Janssen-Cilag and Eli Lilly to their employing institution; has received personal fees from the Finnish Medicines Agency (Fimea), European Medicines Agency (EMA), Eli Lilly, Janssen-Cilag, Lundbeck, and Otsuka; is a member of the advisory board for Lundbeck; and has received grants from the Stanley Foundation and the Sigrid Jus&#x000e9;lius Foundation. Tiina Paunio has no COI related to the content of the current manuscript. Outside this work, she has received honoraria for lectures given at Idorsia Pharmaceuticals Ltd Masterclass 2023 and Biogen Workshop 2023. None of the other authors report any financial relationships with commercial interests.</p></sec><sec sec-type="other" id="sec26"><title>Ethical standard</title><p>The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The authors also assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guides on the care and use of laboratory animals.</p></sec><ref-list id="refs1" content-type="normal"><title>References</title><ref id="r1"><mixed-citation publication-type="book" id="ref1"><string-name><surname>Aalto</surname>, <given-names>A.-M.</given-names></string-name>, <string-name><surname>Aro</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Aro</surname>, <given-names>A.</given-names> R.</string-name>, <string-name><surname>M&#x000e4;h&#x000f6;nen</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Aro</surname>, <given-names>A. R.</given-names></string-name> (<year>1995</year>). <source>Rand 36-item health survey 1,0: Suomenkielinen versio terveyteen liittyv&#x000e4;n el&#x000e4;m&#x000e4;nlaadun kyselyst&#x000e4;: Kyselylomake ja k&#x000e4;ytt&#x000f6;ohjeet</source>. <publisher-loc>Helsinki</publisher-loc>: <publisher-name>Stakes</publisher-name>.</mixed-citation></ref><ref id="r2"><mixed-citation publication-type="journal" id="ref2"><string-name><surname>Aickin</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Gensler</surname>, <given-names>H</given-names></string-name>. (<year>1996</year>). <article-title>Adjusting for multiple testing when reporting research results: The Bonferroni vs Holm methods</article-title>. <source>American Journal of Public Health</source>, <volume>86</volume>(<issue>5</issue>), <fpage>726</fpage>&#x02013;<lpage>728</lpage>. <pub-id pub-id-type="doi">10.2105/AJPH.86.5.726</pub-id><pub-id pub-id-type="pmid">8629727</pub-id>
</mixed-citation></ref><ref id="r3"><mixed-citation publication-type="journal" id="ref3"><string-name><surname>Allardyce</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Leonenko</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Hamshere</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pardi&#x000f1;as</surname>, <given-names>A. F.</given-names></string-name>, <string-name><surname>Forty</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Knott</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Gordon-Smith</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Porteous</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Haywood</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Di Florio</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>McIntosh</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Owen</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Holmans</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Walters</surname>, <given-names>J. T. R.</given-names></string-name>, <string-name><surname>Craddock</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>O&#x02019;Donovan</surname>, <given-names>M. C.</given-names></string-name>, &#x00026; <string-name><surname>Escott-Price</surname>, <given-names>V.</given-names></string-name> (<year>2018</year>). <article-title>Association between schizophrenia-related polygenic liability and the occurrence and level of mood-incongruent psychotic symptoms in bipolar disorder</article-title>. <source>JAMA Psychiatry</source>, <volume>75</volume>(<issue>1</issue>), <fpage>28</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2017.3485</pub-id><pub-id pub-id-type="pmid">29167880</pub-id>
</mixed-citation></ref><ref id="r4"><mixed-citation publication-type="book" id="ref4"><string-name><surname>Aromaa</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>Koskinen</surname>, <given-names>S</given-names></string-name>. (<year>2004</year>). <source>Health and functional capacity in Finland: Baseline results of the health 2000 health examination surbey</source>. <publisher-loc>Helsinki</publisher-loc><italic toggle="yes">:</italic>
<publisher-name>Publications of the National Public Health Institute</publisher-name>.</mixed-citation></ref><ref id="r5"><mixed-citation publication-type="journal" id="ref5"><string-name><surname>Austin-Zimmerman</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Levey</surname>, <given-names>D. F.</given-names></string-name>, <string-name><surname>Giannakopoulou</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Deak</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Galimberti</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Adhikari</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Denaxas</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Irizar</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kuchenbaecker</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>McQuillin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Concato</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Buysse</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Gaziano</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Gottlieb</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Polimanti</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Stein</surname>, <given-names>M. B.</given-names></string-name>, <string-name><surname>Bramon</surname>, <given-names>E.</given-names></string-name>, &#x00026; <string-name><surname>Gelernter</surname>, <given-names>J</given-names></string-name>. (<year>2023</year>). <article-title>Genome-wide association studies and cross-population meta-analyses investigating short and long sleep duration</article-title>. <source>Nature Communications</source>, <volume>14</volume>(<issue>1</issue>), 6059. <pub-id pub-id-type="doi">10.1038/s41467-023-41249-y</pub-id></mixed-citation></ref><ref id="r6"><mixed-citation publication-type="journal" id="ref6"><string-name><surname>Barch</surname>, <given-names>D. M.</given-names></string-name>, &#x00026; <string-name><surname>Ceaser</surname>, <given-names>A</given-names></string-name>. (<year>2012</year>). <article-title>Cognition in schizophrenia: Core psychological and neural mechanisms</article-title>. <source>Trends in Cognitive Sciences</source>, <volume>16</volume>(<issue>1</issue>), 27&#x02013;34. <pub-id pub-id-type="doi">10.1016/j.tics.2011.11.015</pub-id></mixed-citation></ref><ref id="r7"><mixed-citation publication-type="journal" id="ref7"><string-name><surname>Berwick</surname>, <given-names>D. M.</given-names></string-name>, <string-name><surname>Murphy</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Goldman</surname>, <given-names>P. A.</given-names></string-name>, <string-name><surname>Ware</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Barsky</surname>, <given-names>A. J.</given-names></string-name>, &#x00026; <string-name><surname>Weinstein</surname>, <given-names>M. C.</given-names></string-name> (<year>1991</year>). <article-title>Performance of a five-item mental health screening test</article-title>. <source>Medical Care</source>, <volume>29</volume>(<issue>2</issue>), 169&#x02013;176. <pub-id pub-id-type="doi">10.1097/00005650-199102000-00008</pub-id></mixed-citation></ref><ref id="r8"><mixed-citation publication-type="other" id="ref8"><collab>
<italic toggle="yes">CANTAB&#x000ae; [Cognitive Assessment Software]</italic>
</collab>. (<year>2019</year>). <italic toggle="yes">Cambridge cognition.</italic>
<uri xlink:href="http://www.cantab.com">www.cantab.com</uri>.</mixed-citation></ref><ref id="r9"><mixed-citation publication-type="journal" id="ref9"><string-name><surname>Cederl&#x000f6;f</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Holm</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>L&#x000e4;hteenvuo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Haaki</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Hietala</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>H&#x000e4;kkinen</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Isomets&#x000e4;</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Jukuri</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kajanne</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Kampman</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Kiesepp&#x000e4;</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Lahdensuo</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>L&#x000f6;nnqvist</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>M&#x000e4;nnynsalo</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Niemi-Pyntt&#x000e4;ri</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Suokas</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Suvisaari</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Tiihonen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Turunen</surname>, <given-names>H.</given-names></string-name>, &#x02026; <string-name><surname>Paunio</surname>, <given-names>T</given-names></string-name>. (<year>2022</year>). <article-title>Sleep in psychotic disorders: Results from nationwide SUPER Finland study</article-title>. <source>Schizophrenia Bulletin Open</source>, <volume>3</volume>(<issue>1</issue>), <fpage>sgac011</fpage>.<pub-id pub-id-type="pmid">39144769</pub-id>
</mixed-citation></ref><ref id="r10"><mixed-citation publication-type="journal" id="ref10"><string-name><surname>Cederl&#x000f6;f</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Holm</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Taipale</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Tiihonen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Tanskanen</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>L&#x000e4;hteenvuo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lahdensuo</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Kampman</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Wegelius</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Isomets&#x000e4;</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Kiesepp&#x000e4;</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Palotie</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Suvisaari</surname>, <given-names>J.</given-names></string-name>, &#x00026; <string-name><surname>Paunio</surname>, <given-names>T</given-names></string-name>. (<year>2024</year>). <article-title>Antipsychotic medications and sleep problems in patients with schizophrenia</article-title>. <source>Schizophrenia Research</source>, <volume>267</volume>, <fpage>230</fpage>&#x02013;<lpage>238</lpage>.<pub-id pub-id-type="pmid">38579432</pub-id>
</mixed-citation></ref><ref id="r11"><mixed-citation publication-type="journal" id="ref11"><string-name><surname>Dashti</surname>, <given-names>H. S.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Wood</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Lane</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>van Hees</surname>, <given-names>V. T.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Rhodes</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Patel</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Anderson</surname>, <given-names>S. G.</given-names></string-name>, <string-name><surname>Beaumont</surname>, <given-names>R. N.</given-names></string-name>, <string-name><surname>Bechtold</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Bowden</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Cade</surname>, <given-names>B. E.</given-names></string-name>, <string-name><surname>Garaulet</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kyle</surname>, <given-names>S. D.</given-names></string-name>, <string-name><surname>Little</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Loudon</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Luik</surname>, <given-names>A. I.</given-names></string-name>, &#x02026; <string-name><surname>Saxena</surname>, <given-names>R</given-names></string-name>. (<year>2019</year>). <article-title>Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates</article-title>. <source>Nature Communications</source>, <volume>10</volume>(<issue>1</issue>), <fpage>1100</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-08917-4</pub-id></mixed-citation></ref><ref id="r12"><mixed-citation publication-type="journal" id="ref12"><string-name><surname>Dashti</surname>, <given-names>H. S.</given-names></string-name>, <string-name><surname>Redline</surname>, <given-names>S.</given-names></string-name>, &#x00026; <string-name><surname>Saxena</surname>, <given-names>R</given-names></string-name>. (<year>2019</year>). <article-title>Polygenic risk score identifies associations between sleep duration and diseases determined from an electronic medical record biobank</article-title>. <source>Sleep</source>, <volume>42</volume>(<issue>3</issue>), <fpage>zsy247</fpage>. <pub-id pub-id-type="doi">10.1093/sleep/zsy247</pub-id><pub-id pub-id-type="pmid">30521049</pub-id>
</mixed-citation></ref><ref id="r13"><mixed-citation publication-type="journal" id="ref13"><string-name><surname>Demant</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Vinberg</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kessing</surname>, <given-names>L. V.</given-names></string-name>, &#x00026; <string-name><surname>Miskowiak</surname>, <given-names>K. W.</given-names></string-name> (<year>2015</year>). <article-title>Assessment of subjective and objective cognitive function in bipolar disorder: Correlations, predictors and the relation to psychosocial function</article-title>. <source>Psychiatry Research</source>, <volume>229</volume>(<issue>1&#x02013;2</issue>, <fpage>022</fpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2015.05.022</pub-id></mixed-citation></ref><ref id="r14"><mixed-citation publication-type="journal" id="ref14"><string-name><surname>DeRosse</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Nitzburg</surname>, <given-names>G. C.</given-names></string-name>, <string-name><surname>Blair</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Malhotra</surname>, <given-names>A. K.</given-names></string-name> (<year>2018</year>). <article-title>Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults</article-title>. <source>Schizophrenia Research</source>, <volume>195</volume>, <fpage>018</fpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2017.10.018</pub-id></mixed-citation></ref><ref id="r15"><mixed-citation publication-type="journal" id="ref15"><string-name><surname>Devlin</surname>, <given-names>N. J.</given-names></string-name>, &#x00026; <string-name><surname>Krabbe</surname>, <given-names>P.F. M.</given-names></string-name> (<year>2013</year>). <article-title>The development of new research methods for the valuation of EQ-5D-5L</article-title>. <source>European Journal of Health Economics</source>, <volume>14</volume><issue>Suppl. 1</issue>), <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1007/s10198-013-0502-3</pub-id></mixed-citation></ref><ref id="r16"><mixed-citation publication-type="journal" id="ref16"><string-name><surname>Dong</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y. S.</given-names></string-name>, <string-name><surname>Ng</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Ungvari</surname>, <given-names>G. S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Meng</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, &#x00026; <string-name><surname>Xiang</surname>, <given-names>Y. T</given-names></string-name>. (<year>2019</year>). <article-title>Quality of life in Schizophrenia: A meta-analysis of comparative studies</article-title>. <source>Psychiatric Quarterly</source>, <volume>90</volume>(<issue>3</issue>), <fpage>4</fpage>. <pub-id pub-id-type="doi">10.1007/s11126-019-09633-4</pub-id></mixed-citation></ref><ref id="r17"><mixed-citation publication-type="journal" id="ref17"><string-name><surname>Elkis</surname>, <given-names>H.</given-names></string-name>, &#x00026; <string-name><surname>Buckley</surname>, <given-names>P. F.</given-names></string-name> (<year>2016</year>). <article-title>Treatment-resistant schizophrenia</article-title>. In <source>Psychiatric Clinics of North America</source>, <volume>39</volume>, <issue>2</issue>), <fpage>006</fpage>. <pub-id pub-id-type="doi">10.1016/j.psc.2016.01.006</pub-id></mixed-citation></ref><ref id="r18"><mixed-citation publication-type="journal" id="ref18"><string-name><surname>Ferrarelli</surname>, <given-names>F</given-names></string-name>. (<year>2021</year>). <article-title>Sleep abnormalities in schizophrenia: State of the art and next steps</article-title>. <source>The American Journal of Psychiatry</source>, <volume>178</volume>(<issue>10</issue>), 903&#x02013;913. <pub-id pub-id-type="doi">10.1176/appi.ajp.2020.20070968</pub-id></mixed-citation></ref><ref id="r19"><mixed-citation publication-type="journal" id="ref19"><string-name><surname>Foldager</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Peppard</surname>, <given-names>P. E.</given-names></string-name>, <string-name><surname>Hagen</surname>, <given-names>E. W.</given-names></string-name>, <string-name><surname>Stone</surname>, <given-names>K. L.</given-names></string-name>, <string-name><surname>Evans</surname>, <given-names>D. S.</given-names></string-name>, <string-name><surname>Tranah</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>S&#x000f8;rensen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Jennum</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Mignot</surname>, <given-names>E.</given-names></string-name>, &#x00026; <string-name><surname>Schneider</surname>, <given-names>L. D.</given-names></string-name> (<year>2022</year>). <article-title>Genetic risk for subjective reports of insomnia associates only weakly with polygraphic measures of insomnia in 2,770 adults</article-title>. <source>Journal of Clinical Sleep Medicine</source>, <volume>18</volume>(<issue>1</issue>), <fpage>9468</fpage>. <pub-id pub-id-type="doi">10.5664/jcsm.9468</pub-id></mixed-citation></ref><ref id="r20"><mixed-citation publication-type="journal" id="ref20"><string-name><surname>Freeman</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Sheaves</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Waite</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Harvey</surname>, <given-names>A. G.</given-names></string-name>, &#x00026; <string-name><surname>Harrison</surname>, <given-names>P. J.</given-names></string-name> (<year>2020</year>). <article-title>Sleep disturbance and psychiatric disorders</article-title>. <source>The Lancet Psychiatry</source>, <volume>7</volume>(<issue>7</issue>), <fpage>628</fpage>&#x02013;<lpage>637</lpage>.<pub-id pub-id-type="pmid">32563308</pub-id>
</mixed-citation></ref><ref id="r21"><mixed-citation publication-type="journal" id="ref21"><string-name><surname>Ge</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>C. Y.</given-names></string-name>, <string-name><surname>Ni</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Feng</surname>, <given-names>Y. C. A.</given-names></string-name>, &#x00026; <string-name><surname>Smoller</surname>, <given-names>J. W.</given-names></string-name> (<year>2019</year>). <article-title>Polygenic prediction via Bayesian regression and continuous shrinkage priors</article-title>. <source>Nature Communications</source>, <volume>10</volume>(<issue>1</issue>), <fpage>5</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-09718-5</pub-id></mixed-citation></ref><ref id="r22"><mixed-citation publication-type="journal" id="ref22"><string-name><surname>Gonzalez</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Tamminga</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Tohen</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Suppes</surname>, <given-names>T.</given-names></string-name> (<year>2013</year>). <article-title>Comparison of objective and subjective assessments of sleep time in subjects with bipolar disorder</article-title>. <source>Journal of Affective Disorders</source>, <volume>149</volume>(<issue>1&#x02013;3</issue>), <fpage>363</fpage>&#x02013;<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2013.02.013</pub-id><pub-id pub-id-type="pmid">23489400</pub-id>
</mixed-citation></ref><ref id="r23"><mixed-citation publication-type="journal" id="ref23"><string-name><surname>Green</surname>, <given-names>M. F.</given-names></string-name>, &#x00026; <string-name><surname>Harvey</surname>, <given-names>P. D.</given-names></string-name> (<year>2014</year>). <article-title>Cognition in schizophrenia: Past, present, and future</article-title>. <source>Schizophrenia Research: Cognition</source>, <volume>1</volume>(<issue>1</issue>), e1&#x02013;e9. <pub-id pub-id-type="doi">10.1016/j.scog.2014.02.001</pub-id></mixed-citation></ref><ref id="r24"><mixed-citation publication-type="journal" id="ref24"><string-name><surname>Green</surname>, <given-names>M. F.</given-names></string-name>, <string-name><surname>Kern</surname>, <given-names>R. S.</given-names></string-name>, &#x00026; <string-name><surname>Heaton</surname>, <given-names>R. K.</given-names></string-name> (<year>2004</year>). <article-title>Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS</article-title>. <source>Schizophrenia Research</source>, <volume>72</volume>(<issue>1</issue>), 009. <pub-id pub-id-type="doi">10.1016/j.schres.2004.09.009</pub-id></mixed-citation></ref><ref id="r25"><mixed-citation publication-type="book" id="ref25"><string-name><surname>Heistaro</surname>, <given-names>S</given-names></string-name>. (<year>2008</year>). <source>Methodology report. Health 2000 survey</source>. <publisher-loc>Helsinki</publisher-loc><italic toggle="yes">:</italic>
<publisher-name>Publications of the National Health Institute</publisher-name>. <uri xlink:href="http://www.terveys2000.fi">http://www.terveys2000.fi</uri></mixed-citation></ref><ref id="r26"><mixed-citation publication-type="journal" id="ref26"><string-name><surname>Hertenstein</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Benz</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Schneider</surname>, <given-names>C. L.</given-names></string-name>, &#x00026; <string-name><surname>Baglioni</surname>, <given-names>C</given-names></string-name>. (<year>2023</year>). <article-title>Insomnia&#x02014;A risk factor for mental disorders</article-title>. <source>Journal of Sleep Research</source>, <volume>32</volume>(<issue>6</issue>), <fpage>13930</fpage>. <pub-id pub-id-type="doi">10.1111/jsr.13930</pub-id></mixed-citation></ref><ref id="r27"><mixed-citation publication-type="journal" id="ref27"><string-name><surname>Holm</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Taipale</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Tanskanen</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Tiihonen</surname>, <given-names>J.</given-names></string-name>, &#x00026; <string-name><surname>Mitterdorfer-Rutz</surname>, <given-names>E</given-names></string-name>. (<year>2021</year>). <article-title>Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers</article-title>. <source>Acta Psychiatrica Scandinavica</source>, <volume>143</volume>(<issue>1</issue>), 61&#x02013;71. <pub-id pub-id-type="doi">10.1111/acps.13254</pub-id></mixed-citation></ref><ref id="r28"><mixed-citation publication-type="journal" id="ref28"><string-name><surname>Homayoun</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Nadeau-Marcotte</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Luck</surname>, <given-names>D.</given-names></string-name>, &#x00026; <string-name><surname>Stip</surname>, <given-names>E.</given-names></string-name>. (<year>2011</year>). <article-title>Subjective and objective cognitive dysfunction in schizophrenia is there a link?</article-title>
<source>Frontiers in Psychology</source>, <volume>2</volume>, 148. <pub-id pub-id-type="doi">10.3389/fpsyg.2011.00148</pub-id></mixed-citation></ref><ref id="r29"><mixed-citation publication-type="journal" id="ref29"><string-name><surname>Jansen</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Watanabe</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Stringer</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Skene</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bryois</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hammerschlag</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>de Leeuw</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Benjamins</surname>, <given-names>J. S.</given-names></string-name>, <string-name><surname>Mu&#x000f1;oz-Manchado</surname>, <given-names>A. B.</given-names></string-name>, <string-name><surname>Nagel</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Savage</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Tiemeier</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>White</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Agee</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Alipanahi</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Auton</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bell</surname>, <given-names>R. K.</given-names></string-name>, <string-name><surname>Bryc</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Elson</surname>, <given-names>S. L.</given-names></string-name>, &#x02026; <string-name><surname>Posthuma</surname>, <given-names>D</given-names></string-name>. (<year>2019</year>). <article-title>Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways</article-title>. <source>Nature Genetics</source>, <volume>51</volume>(<issue>3</issue>), 394&#x02013;403. <pub-id pub-id-type="doi">10.1038/s41588-018-0333-3</pub-id></mixed-citation></ref><ref id="r30"><mixed-citation publication-type="journal" id="ref30"><string-name><surname>Jonas</surname>, <given-names>K. G.</given-names></string-name>, <string-name><surname>Lencz</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Malhotra</surname>, <given-names>A. K.</given-names></string-name>, <string-name><surname>Perlman</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Fochtmann</surname>, <given-names>L. J.</given-names></string-name>, <string-name><surname>Bromet</surname>, <given-names>E. J.</given-names></string-name>, &#x00026; <string-name><surname>Kotov</surname>, <given-names>R</given-names></string-name>. (<year>2019</year>). <article-title>Schizophrenia polygenic risk score and 20-year course of illness in psychotic disorders</article-title>. <source>Translational Psychiatry</source>, <volume>9</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.1038/s41398-019-0612-5</pub-id></mixed-citation></ref><ref id="r31"><mixed-citation publication-type="journal" id="ref31"><string-name><surname>Jones</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Lane</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Wood</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>van Hees</surname>, <given-names>V. T.</given-names></string-name>, <string-name><surname>Tyrrell</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Beaumont</surname>, <given-names>R. N.</given-names></string-name>, <string-name><surname>Jeffries</surname>, <given-names>A. R.</given-names></string-name>, <string-name><surname>Dashti</surname>, <given-names>H. S.</given-names></string-name>, <string-name><surname>Hillsdon</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ruth</surname>, <given-names>K. S.</given-names></string-name>, <string-name><surname>Tuke</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Yaghootkar</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Sharp</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Jie</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Thompson</surname>, <given-names>W. D.</given-names></string-name>, <string-name><surname>Harrison</surname>, <given-names>J. W.</given-names></string-name>, <string-name><surname>Dawes</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Byrne</surname>, <given-names>E. M.</given-names></string-name>, <string-name><surname>Tiemeier</surname>, <given-names>H.</given-names></string-name>, &#x02026; <string-name><surname>Weedon</surname>, <given-names>M. N.</given-names></string-name> (<year>2019</year>). <article-title>Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms</article-title>. <source>Nature Communications</source>, <volume>10</volume>(<issue>1</issue>), 300. <pub-id pub-id-type="doi">10.1038/s41467-018-08259-7</pub-id></mixed-citation></ref><ref id="r32"><mixed-citation publication-type="other" id="ref32"><string-name><surname>Koponen</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Borodulin</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Lundqvist</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>S&#x000e4;&#x000e4;ksj&#x000e4;rvi</surname>, <given-names>K.</given-names></string-name>, &#x00026; <string-name><surname>Koskinen</surname>, <given-names>S.</given-names></string-name>. (<year>2018</year>). Health, functional capacity and welfare in Finland&#x02014;FinHealth 2017 study. <source>THL-report 4/2018</source>.</mixed-citation></ref><ref id="r33"><mixed-citation publication-type="journal" id="ref33"><string-name><surname>Krystal</surname>, <given-names>A. D.</given-names></string-name> (<year>2012</year>). <article-title>Psychiatric disorders and sleep</article-title>. <source>Neurologic Clinics</source>, <volume>30</volume>(<issue>4</issue>), <fpage>1389</fpage>&#x02013;<lpage>1413</lpage>. <pub-id pub-id-type="doi">10.1016/j.ncl.2012.08.018</pub-id><pub-id pub-id-type="pmid">23099143</pub-id>
</mixed-citation></ref><ref id="r34"><mixed-citation publication-type="journal" id="ref34"><string-name><surname>Kurki</surname>, <given-names>M. I.</given-names></string-name>, <string-name><surname>Karjalainen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Palta</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Sipil&#x000e4;</surname>, <given-names>T. P.</given-names></string-name>, <string-name><surname>Kristiansson</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Donner</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Reeve</surname>, <given-names>M. P.</given-names></string-name>, <string-name><surname>Laivuori</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Aavikko</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kaunisto</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Loukola</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lahtela</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Mattsson</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Laiho</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Parolo</surname>, <given-names>D. B.</given-names></string-name>, <string-name><surname>Pietro</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Arto</surname>
<given-names>A.</given-names></string-name>, <string-name><surname>Kanai</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mars</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>R&#x000e4;m&#x000f6;</surname>, <given-names>J.</given-names></string-name>, &#x02026; <string-name><surname>Palotie</surname>, <given-names>A</given-names></string-name>. (<year>2023</year>). <article-title>FinnGen provides genetic insights from a well-phenotyped isolated population</article-title>. <source>Nature</source>, <volume>613</volume>(<issue>7944</issue>), 508&#x02013;518. <pub-id pub-id-type="doi">10.1038/s41586-022-05473-8</pub-id></mixed-citation></ref><ref id="r35"><mixed-citation publication-type="journal" id="ref35"><string-name><surname>L&#x000e4;hteenvuo</surname>
<given-names>M.</given-names></string-name>, <string-name><surname>Ahola-Olli</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Suokas</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Holm</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Misiewicz</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Jukuri</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>M&#x000e4;nnynsalo</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Wegelius</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Haaki</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Kajanne</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Kytt&#x000e4;l&#x000e4;</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Tuulio-Henriksson</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lahdensuo</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>H&#x000e4;kkinen</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Hietala</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Paunio</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Niemi-Pyntt&#x000e4;ri</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kiesepp&#x000e4;</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Veijola</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>L&#x000f6;nnqvist</surname>, <given-names>J.</given-names></string-name>, &#x02026; <string-name><surname>Palotie</surname>, <given-names>A</given-names></string-name>. (<year>2023</year>). <article-title>Cohort profile: SUPER-Finland &#x02013; the Finnish study for hereditary mechanisms of psychotic disorders</article-title>. <source>BMJ Open</source>, <volume>13</volume>, <fpage>e070710</fpage>.</mixed-citation></ref><ref id="r36"><mixed-citation publication-type="journal" id="ref36"><string-name><surname>Lane</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Liang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Vlasac</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Anderson</surname>, <given-names>S. G.</given-names></string-name>, <string-name><surname>Bechtold</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Bowden</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Emsley</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Gill</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Little</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Luik</surname>, <given-names>A. I.</given-names></string-name>, <string-name><surname>Loudon</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Scheer</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Purcell</surname>, <given-names>A. J. L.</given-names></string-name>, <string-name><surname>Shaun</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kyle</surname>, <given-names>S. D.</given-names></string-name>, <string-name><surname>Lawlor</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Redline</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ray</surname>, <given-names>D. W.</given-names></string-name>, <string-name><surname>Rutter</surname>, <given-names>M. K.</given-names></string-name>, &#x00026; <string-name><surname>Saxena</surname>, <given-names>R</given-names></string-name>. (<year>2017</year>). <article-title>Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits</article-title>. <source>Nature Genetics</source>, <volume>49</volume>(<issue>2</issue>), <fpage>3749</fpage>. <pub-id pub-id-type="doi">10.1038/ng.3749</pub-id></mixed-citation></ref><ref id="r37"><mixed-citation publication-type="journal" id="ref37"><string-name><surname>Lepage</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bodnar</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Bowie</surname>, <given-names>C. R.</given-names></string-name> (<year>2014</year>). <article-title>Neurocognition: Clinical and functional outcomes in schizophrenia</article-title>. <source>Canadian Journal of Psychiatry</source>, <volume>59</volume><issue>1</issue>), <fpage>103</fpage>. <pub-id pub-id-type="doi">10.1177/070674371405900103</pub-id></mixed-citation></ref><ref id="r38"><mixed-citation publication-type="journal" id="ref38"><string-name><surname>Li</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>F. C.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Ng</surname>, <given-names>C. H.</given-names></string-name>, <string-name><surname>Ungvari</surname>, <given-names>G. S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, &#x00026; <string-name><surname>Xiang</surname>, <given-names>Y. T</given-names></string-name>. (<year>2020</year>). <article-title>Comparison of cognitive dysfunction between schizophrenia and bipolar disorder patients: A meta-analysis of comparative studies</article-title>. <source>Journal of Affective Disorders</source>, <volume>274</volume>, <fpage>051</fpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2020.04.051</pub-id></mixed-citation></ref><ref id="r39"><mixed-citation publication-type="journal" id="ref39"><string-name><surname>Lin</surname>, <given-names>B. D.</given-names></string-name>, <string-name><surname>Pinz&#x000f3;n-Espinosa</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Blouzard</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Van Der Horst</surname>, <given-names>M. Z.</given-names></string-name>, <string-name><surname>Okhuijsen-Pfeifer</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Van Eijk</surname>, <given-names>K. R.</given-names></string-name>, <string-name><surname>Guloksuz</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Peyrot</surname>, <given-names>W. J.</given-names></string-name>, &#x00026; <string-name><surname>Luykx</surname>, <given-names>J. J.</given-names></string-name> (<year>2023</year>). <article-title>Associations between polygenic risk score loading, psychosis liability, and clozapine use among individuals with schizophrenia</article-title>. <source>JAMA Psychiatry</source>, <volume>80</volume>(<issue>2</issue>), <fpage>4234</fpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2022.4234</pub-id></mixed-citation></ref><ref id="r40"><mixed-citation publication-type="journal" id="ref40"><string-name><surname>Linke</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Jankowski</surname>, <given-names>K. S.</given-names></string-name> (<year>2021</year>). <article-title>Chronotype in individuals with schizophrenia: A meta-analysis</article-title>. <source>Schizophrenia Research</source>, <volume>235</volume>, <fpage>020</fpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2021.07.020</pub-id></mixed-citation></ref><ref id="r41"><mixed-citation publication-type="journal" id="ref41"><string-name><surname>Mallet</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Strat</surname>, <given-names>Y. L.</given-names></string-name>, <string-name><surname>Dubertret</surname>, <given-names>C.</given-names></string-name>, &#x00026; <string-name><surname>Gorwood</surname>, <given-names>P</given-names></string-name>. (<year>2020</year>). <article-title>Polygenic risk scores shed light on the relationship between schizophrenia and cognitive functioning: Review and meta-analysis</article-title>. <source>Journal of Clinical Medicine</source>, <volume>9</volume>(<issue>2</issue>), <fpage>341</fpage>. <pub-id pub-id-type="doi">10.3390/jcm9020341</pub-id><pub-id pub-id-type="pmid">31991840</pub-id>
</mixed-citation></ref><ref id="r42"><mixed-citation publication-type="journal" id="ref42"><string-name><surname>Meier</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Agerbo</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Maier</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Pedersen</surname>, <given-names>C. B.</given-names></string-name>, <string-name><surname>Lang</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Grove</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hollegaard</surname>, <given-names>M. V.</given-names></string-name>, <string-name><surname>Demontis</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Trabjerg</surname>, <given-names>B. B.</given-names></string-name>, <string-name><surname>Hjorth&#x000d8;j</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ripke</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Degenhardt</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>N&#x000f6;then</surname>, <given-names>M. M.</given-names></string-name>, <string-name><surname>Rujescu</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Maier</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Werge</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Mors</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Hougaard</surname>, <given-names>D. M.</given-names></string-name>, <string-name><surname>B&#x000d8;rglum</surname>, <given-names>A. D.</given-names></string-name>, &#x02026; <string-name><surname>Mattheisen</surname>, <given-names>M.</given-names></string-name> (<year>2016</year>). <article-title>High loading of polygenic risk in cases with chronic schizophrenia</article-title>. <source>Molecular Psychiatry</source>, <volume>21</volume>(<issue>7</issue>), <fpage>130</fpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.130</pub-id></mixed-citation></ref><ref id="r43"><mixed-citation publication-type="journal" id="ref43"><string-name><surname>Melhuish Beaupre</surname>, <given-names>L.M.</given-names></string-name>, <string-name><surname>Tiwari</surname>, <given-names>A. K.</given-names></string-name>, <string-name><surname>Gon&#x000e7;alves</surname>, <given-names>V. F.</given-names></string-name>, <string-name><surname>Zai</surname>, <given-names>C. C.</given-names></string-name>, <string-name><surname>Marshe</surname>, <given-names>V. S.</given-names></string-name>, <string-name><surname>Lewis</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Martin</surname>, <given-names>N. G.</given-names></string-name>, <string-name><surname>McIntosh</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Adams</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Baune</surname>, <given-names>B. T.</given-names></string-name>, <string-name><surname>Levinson</surname>, <given-names>D. F.</given-names></string-name>, <string-name><surname>Boomsma</surname>, <given-names>D. I.</given-names></string-name>, <string-name><surname>Penninx</surname>, <given-names>B. W. J. H.</given-names></string-name>, <string-name><surname>Breen</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Hamilton</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Awasthi</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ripke</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>I.</given-names></string-name>, &#x02026; <string-name><surname>Kennedy</surname>, <given-names>J. L.</given-names></string-name> (<year>2021</year>). <article-title>Potential genetic overlap between insomnia and sleep symptoms in major depressive disorder: A polygenic risk score analysis</article-title>. <source>Frontiers in Psychiatry</source>, <volume>12</volume>, <fpage>077</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyt.2021.734077</pub-id></mixed-citation></ref><ref id="r44"><mixed-citation publication-type="journal" id="ref44"><string-name><surname>Mongrain</surname>, <given-names>V.</given-names></string-name>, &#x00026; <string-name><surname>Dumont</surname>, <given-names>M</given-names></string-name>. (<year>2007</year>). <article-title>Increased homeostatic response to behavioral sleep fragmentation in morning types compared to evening types</article-title>. <source>Sleep</source>, <volume>30</volume>(<issue>6</issue>), <fpage>773</fpage>. <pub-id pub-id-type="doi">10.1093/sleep/30.6.773</pub-id><pub-id pub-id-type="pmid">17580599</pub-id>
</mixed-citation></ref><ref id="r45"><mixed-citation publication-type="journal" id="ref45"><string-name><surname>Nagelkerke</surname>, <given-names>N. J. D.</given-names></string-name> (<year>1991</year>). <article-title>A note on a general definition of the coefficient of determination</article-title>. <source>Biometrika</source>, <volume>78</volume>, <issue>3</issue>), <fpage>691</fpage>. <pub-id pub-id-type="doi">10.1093/biomet/78.3.691</pub-id></mixed-citation></ref><ref id="r46"><mixed-citation publication-type="journal" id="ref46"><string-name><surname>Norbury</surname>, <given-names>Ray</given-names></string-name>. (<year>2021</year>). <article-title>Diurnal preference and depressive symptomatology: A meta-analysis</article-title>. <source>Scientific Reports</source>, <volume>11</volume>(<issue>1</issue>), <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-91205-3</pub-id><pub-id pub-id-type="pmid">33420163</pub-id>
</mixed-citation></ref><ref id="r47"><mixed-citation publication-type="journal" id="ref47"><string-name><surname>O&#x02019;Connell</surname>, <given-names>K. S.</given-names></string-name>, <string-name><surname>Frei</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Bahrami</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Smeland</surname>, <given-names>O. B.</given-names></string-name>, <string-name><surname>Bettella</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Chu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Hindley</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Shadrin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Barrett</surname>, <given-names>E. A.</given-names></string-name>, <string-name><surname>Lagerberg</surname>, <given-names>T. V.</given-names></string-name>, <string-name><surname>Steen</surname>, <given-names>N. E.</given-names></string-name>, <string-name><surname>Dale</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Djurovic</surname>, <given-names>S.</given-names></string-name>, &#x00026; <string-name><surname>Andreassen</surname>, <given-names>O. A.</given-names></string-name> (<year>2021</year>). <article-title>Characterizing the genetic overlap between psychiatric disorders and sleep-related phenotypes</article-title>. <source>Biological Psychiatry</source>, <volume>90</volume>(<issue>9</issue>), <fpage>007</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2021.07.007</pub-id></mixed-citation></ref><ref id="r48"><mixed-citation publication-type="journal" id="ref48"><string-name><surname>Palmer</surname>, <given-names>B. W.</given-names></string-name>, <string-name><surname>Dawes</surname>, <given-names>S. E.</given-names></string-name>, &#x00026; <string-name><surname>Heaton</surname>, <given-names>R. K.</given-names></string-name> (<year>2009</year>). <article-title>What do we know about neuropsychological aspects of schizophrenia?</article-title>
<source>Neuropsychology Review</source>, <volume>19</volume>(<issue>3</issue>), <fpage>365</fpage>&#x02013;<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1007/s11065-009-9109-y</pub-id><pub-id pub-id-type="pmid">19639412</pub-id>
</mixed-citation></ref><ref id="r49"><mixed-citation publication-type="other" id="ref49"><string-name>
<surname>P&#x000e4;rn</surname>
</string-name>
<etal>et al.</etal> (<year>n.d.</year>). <italic toggle="yes">THL Biobank&#x02019;s SISu v3 WGS imputation reference panel.</italic> Retrieved January 21, 2025, from <uri xlink:href="https://thl.fi/documents/155392151/190122041/THL+Biobank+Imputation+Panel.pdf/49bd9ba3-9d6d-481b-b645-18e1a58edbee/THL+Biobank+Imputation+Panel.pdf?t=1540898079794">https://thl.fi/documents/155392151/190122041/THL+Biobank+Imputation+Panel.pdf/49bd9ba3-9d6d-481b-b645-18e1a58edbee/THL+Biobank+Imputation+Panel.pdf?t=1540898079794</uri></mixed-citation></ref><ref id="r50"><mixed-citation publication-type="journal" id="ref50"><string-name><surname>Partinen</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Gislason</surname>, <given-names>T</given-names></string-name>. (<year>1995</year>). <article-title>Basic Nordic Sleep Questionnaire (BNSQ): A quantitated measure of subjective sleep complaints</article-title>. <source>Journal of Sleep Research</source>, <volume>4</volume>, <fpage>150</fpage>&#x02013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2869.1995.tb00205.x</pub-id></mixed-citation></ref><ref id="r51"><mixed-citation publication-type="journal" id="ref51"><string-name><surname>Prouteau</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Roux</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Destaillats</surname>, <given-names>J. M.</given-names></string-name>, &#x00026; <string-name><surname>Bergua</surname>, <given-names>V</given-names></string-name>. (<year>2017</year>). <article-title>Profiles of relationships between subjective and objective cognition in schizophrenia: Associations with quality of life, stigmatization, and mood factors</article-title>. <source>Journal of Cognitive Education and Psychology</source>, <volume>16</volume>(<issue>1</issue>), <fpage>64</fpage>. <pub-id pub-id-type="doi">10.1891/1945-8959.16.1.64</pub-id></mixed-citation></ref><ref id="r52"><mixed-citation publication-type="journal" id="ref52"><string-name><surname>Raffard</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lebrun</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Bayard</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Macgregor</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>Capdevielle</surname>, <given-names>D</given-names></string-name>. (<year>2020</year>). <article-title>Self-awareness deficits of cognitive impairment in individuals with schizophrenia. Really?</article-title>
<source>Frontiers in Psychiatry</source>, <volume>11</volume>, <fpage>731</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyt.2020.00731</pub-id><pub-id pub-id-type="pmid">32848912</pub-id>
</mixed-citation></ref><ref id="r53"><mixed-citation publication-type="journal" id="ref53"><string-name><surname>Raha</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>B. D.</given-names></string-name>, <string-name><surname>van Eijk</surname>, <given-names>K. R.</given-names></string-name>, <string-name><surname>Schijven</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>de Zwarte</surname>, <given-names>S.</given-names></string-name>, <collab>GROUP Investigators</collab>, <string-name><surname>Guloksuz</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Luykx</surname>, <given-names>J. J.</given-names></string-name> (<year>2020</year>). <article-title>Phenome-wide and genome-wide analyses of quality of life in schizophrenia</article-title>. <source>British Journal of Psychiatry Open</source>, <volume>7</volume>(<issue>1</issue>), <fpage>e13</fpage>.<pub-id pub-id-type="pmid">33295273</pub-id>
</mixed-citation></ref><ref id="r54"><mixed-citation publication-type="journal" id="ref54"><string-name><surname>Reeve</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sheaves</surname>, <given-names>B.</given-names></string-name>, &#x00026; <string-name><surname>Freeman</surname>, <given-names>D</given-names></string-name>. (<year>2019</year>). <article-title>Sleep disorders in early psychosis: Incidence, severity, and association with clinical symptoms</article-title>. <source>Schizophrenia Bulletin</source>, <volume>45</volume>(<issue>2</issue>), <fpage>129</fpage>. <pub-id pub-id-type="doi">10.1093/schbul/sby129</pub-id></mixed-citation></ref><ref id="r55"><mixed-citation publication-type="journal" id="ref55"><string-name><surname>Reeve</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sheaves</surname>, <given-names>B.</given-names></string-name>, &#x00026; <string-name><surname>Freeman</surname>, <given-names>D</given-names></string-name>. (<year>2021</year>). <article-title>Excessive sleepiness in patients with psychosis: An initial investigation</article-title>. <source>PLoS One</source>, <volume>16</volume>, <fpage>245301</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0245301</pub-id></mixed-citation></ref><ref id="r56"><mixed-citation publication-type="journal" id="ref56"><string-name><surname>Richards</surname>, <given-names>A. L.</given-names></string-name>, <string-name><surname>Pardi&#x000f1;as</surname>, <given-names>A. F.</given-names></string-name>, <string-name><surname>Frizzati</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Tansey</surname>, <given-names>K. E.</given-names></string-name>, <string-name><surname>Lynham</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Holmans</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Legge</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Savage</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Agartz</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Andreassen</surname>, <given-names>O. A.</given-names></string-name>, <string-name><surname>Blokland</surname>, <given-names>G. A. M.</given-names></string-name>, <string-name><surname>Corvin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Cosgrove</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Degenhardt</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Djurovic</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Espeseth</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Ferraro</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Gayer-Anderson</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Giegling</surname>, <given-names>I.</given-names></string-name>, &#x02026; <string-name><surname>Walters</surname>, <given-names>J. T. R</given-names></string-name>. (<year>2020</year>). <article-title>The relationship between polygenic risk scores and cognition in schizophrenia</article-title>. <source>Schizophrenia Bulletin</source>, <volume>46</volume>(<issue>2</issue>), <fpage>061</fpage>. <pub-id pub-id-type="doi">10.1093/schbul/sbz061</pub-id></mixed-citation></ref><ref id="r57"><mixed-citation publication-type="journal" id="ref57"><string-name><surname>Ritsner</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kurs</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ponizovsky</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>Hadjez</surname>, <given-names>J</given-names></string-name>. (<year>2004</year>). <article-title>Perceived quality of life in schizophrenia: Relationships to sleep quality</article-title>. <source>Quality of Life Research</source>, <volume>13</volume>(<issue>4</issue>), <fpage>783</fpage>&#x02013;<lpage>791</lpage>. <pub-id pub-id-type="doi">10.1023/B:QURE.0000021687.18783.d6</pub-id><pub-id pub-id-type="pmid">15129888</pub-id>
</mixed-citation></ref><ref id="r58"><mixed-citation publication-type="journal" id="ref58"><string-name><surname>Saarni</surname>, <given-names>S. I.</given-names></string-name>, <string-name><surname>H&#x000e4;rk&#x000e4;nen</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Sintonen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Suvisaari</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Koskinen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Aromaa</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>L&#x000f6;nnqvist</surname>, <given-names>J</given-names></string-name>. (<year>2006</year>). <article-title>The impact of 29 chronic conditions on health-related quality of life: A general population survey in Finland using 15D and EQ-5D</article-title>. <source>Quality of Life Research</source>, <volume>15</volume>(<issue>8</issue>), <fpage>1</fpage>. <pub-id pub-id-type="doi">10.1007/s11136-006-0020-1</pub-id><pub-id pub-id-type="pmid">16411026</pub-id>
</mixed-citation></ref><ref id="r59"><mixed-citation publication-type="journal" id="ref59"><string-name><surname>Saarni</surname>, <given-names>S. I.</given-names></string-name>, <string-name><surname>Vierti&#x000f6;</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Per&#x000e4;l&#x000e4;</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Koskinen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>L&#x000f6;nnqvist</surname>, <given-names>J.</given-names></string-name>, &#x00026; <string-name><surname>Suvisaari</surname>, <given-names>J</given-names></string-name>. (<year>2010</year>). <article-title>Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders</article-title>. <source>British Journal of Psychiatry</source>, <volume>197</volume>(<issue>5</issue>), <fpage>76489</fpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.109.076489</pub-id></mixed-citation></ref><ref id="r60"><mixed-citation publication-type="journal" id="ref60"><string-name><surname>Sullivan</surname>, <given-names>P. F.</given-names></string-name>, <string-name><surname>Agrawal</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bulik</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Andreassen</surname>, <given-names>O. A.</given-names></string-name>, <string-name><surname>B&#x000f8;rglum</surname>, <given-names>A. D.</given-names></string-name>, <string-name><surname>Breen</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Cichon</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Edenberg</surname>, <given-names>H. J.</given-names></string-name>, <string-name><surname>Faraone</surname>, <given-names>S. V.</given-names></string-name>, <string-name><surname>Gelernter</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Mathews</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Nievergelt</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Smoller</surname>, <given-names>J. W.</given-names></string-name>, <string-name><surname>O&#x02019;Donovan</surname>, <given-names>M. C.</given-names></string-name>, <string-name><surname>Daly</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gill</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kelsoe</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Koenen</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Levinson</surname>, <given-names>D.</given-names></string-name>, &#x02026; <string-name><surname>Sklar</surname>, <given-names>P</given-names></string-name>. (<year>2018</year>). <article-title>Psychiatric genomics: An update and an agenda</article-title>. <source>American Journal of Psychiatry</source>, <volume>175</volume>(<issue>1</issue>), <fpage>283</fpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2017.17030283</pub-id></mixed-citation></ref><ref id="r61"><mixed-citation publication-type="journal" id="ref61"><string-name><surname>Sund</surname>, <given-names>R</given-names></string-name>. (<year>2012</year>). <article-title>Quality of the Finnish Hospital Discharge Register: A systematic review</article-title>. <source>Scandinavian Journal of Public Health</source>, <volume>40</volume>(<issue>6</issue>), <fpage>637</fpage>. <pub-id pub-id-type="doi">10.1177/1403494812456637</pub-id></mixed-citation></ref><ref id="r62"><mixed-citation publication-type="journal" id="ref62"><string-name><surname>Taillard</surname>, <given-names>J</given-names></string-name>., <string-name><surname>Philip</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Coste</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Sagaspe</surname>, <given-names>P.</given-names></string-name>, &#x00026; <string-name><surname>Bioulac</surname>, <given-names>B</given-names></string-name>. (<year>2003</year>). <article-title>The circadian and homeostatic modulation of sleep pressure during wakefulness differs between morning and evening chronotypes</article-title>. <source>Journal of Sleep Research</source>, <volume>12</volume>(<issue>4</issue>), <fpage>275</fpage>&#x02013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1046/j.0962-1105.2003.00369.x</pub-id><pub-id pub-id-type="pmid">14633238</pub-id>
</mixed-citation></ref><ref id="r63"><mixed-citation publication-type="journal" id="ref63"><string-name><surname>Taliun</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Chothani</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Sch&#x000f6;nherr</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Forer</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Boehnke</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Abecasis</surname>, <given-names>G. R.</given-names></string-name>, &#x00026; <string-name><surname>Wang</surname>, <given-names>C</given-names></string-name>. (<year>2017</year>). <article-title>LASER server: Ancestry tracing with genotypes or sequence reads</article-title>. <source>Bioinformatics</source>, <volume>33</volume>(<issue>13</issue>), <fpage>075</fpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx075</pub-id></mixed-citation></ref><ref id="r64"><mixed-citation publication-type="journal" id="ref64"><string-name><surname>Trubetskoy</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Pardi&#x000f1;as</surname>, <given-names>A. F.</given-names></string-name>, <string-name><surname>Qi</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Panagiotaropoulou</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Awasthi</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bigdeli</surname>, <given-names>T. B.</given-names></string-name>, <string-name><surname>Bryois</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>O&#x02019;Donovan</surname>, <given-names>M. C</given-names></string-name>. (<year>2022</year>). <article-title>Mapping genomic loci implicates genes and synaptic biology in schizophrenia</article-title>. <source>Nature</source>, <volume>604</volume>(<issue>7906</issue>), <fpage>502</fpage>&#x02013;<lpage>508</lpage>.<pub-id pub-id-type="pmid">35396580</pub-id>
</mixed-citation></ref><ref id="r65"><mixed-citation publication-type="journal" id="ref65"><string-name><surname>Wainberg</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>S. E.</given-names></string-name>, <string-name><surname>Beaupre</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Hill</surname>, <given-names>S. L.</given-names></string-name>, <string-name><surname>Felsky</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Rivas</surname>, <given-names>M. A.</given-names></string-name>, <string-name><surname>Lim</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ollila</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Hanna</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Tripathy</surname>, <given-names>S. J.</given-names></string-name> (<year>2021</year>). <article-title>Association of accelerometer-derived sleep measures with lifetime psychiatric diagnoses: A cross-sectional study of 89,205 participants from the UK Biobank</article-title>. <source>PLoS Medicine</source>, <volume>18</volume>(<issue>10</issue>), <fpage>1003782</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1003782</pub-id></mixed-citation></ref><ref id="r66"><mixed-citation publication-type="journal" id="ref66"><string-name><surname>Woodward</surname>, <given-names>A. A.</given-names></string-name>, <string-name><surname>Urbanowicz</surname>, <given-names>R. J.</given-names></string-name>, <string-name><surname>Naj</surname>, <given-names>A. C.</given-names></string-name>, &#x00026; <string-name><surname>Moore</surname>, <given-names>J. H.</given-names></string-name> (<year>2022</year>). <article-title>Genetic heterogeneity: Challenges, impacts, and methods through an associative lens</article-title>. In <source>Genetic Epidemiology</source>, <volume>46</volume>
<issue>8</issue>), <fpage>22497</fpage>. <pub-id pub-id-type="doi">10.1002/gepi.22497</pub-id></mixed-citation></ref><ref id="r67"><mixed-citation publication-type="journal" id="ref67"><string-name><surname>Wray</surname>, <given-names>N. R.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S. H.</given-names></string-name>, <string-name><surname>Mehta</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Vinkhuyzen</surname>, <given-names>A. A. E.</given-names></string-name>, <string-name><surname>Dudbridge</surname>, <given-names>F.</given-names></string-name>, &#x00026; <string-name><surname>Middeldorp</surname>, <given-names>C. M</given-names></string-name>. (<year>2014</year>). <article-title>Research review: Polygenic methods and their application to psychiatric traits</article-title>. <source>Journal of Child Psychology and Psychiatry and Allied Disciplines</source>, <volume>55</volume><issue>10</issue>), <fpage>12295</fpage>. <pub-id pub-id-type="doi">10.1111/jcpp.12295</pub-id></mixed-citation></ref><ref id="r68"><mixed-citation publication-type="journal" id="ref68"><string-name><surname>Zhang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Priv&#x000e9;</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Vilhj&#x000e1;lmsson</surname>, <given-names>B.</given-names></string-name>, &#x00026; <string-name><surname>Speed</surname>, <given-names>D</given-names></string-name>. (<year>2021</year>). <article-title>Improved genetic prediction of complex traits from individual-level data or summary statistics</article-title>. <source>Nature Communications</source>, <volume>12</volume>(<issue>1</issue>), <fpage>4192</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-24485-y</pub-id></mixed-citation></ref></ref-list></back></article>